topic,score
Mpro,1.6574330592176465
Spike,1.580836640572062
Nsp3,0.827800112931166
ACE2,0.6648870126233883
ORF8,0.34814373622183575
SARS-CoV-2,0.34432695309250055
SARS-CoV,0.3210232621738818
E,0.28495333845721915
bat SARSr-CoV WIV1,0.27750000506639483
Nsp7,0.22645124094981803
sarbeco virus,0.1941547470787151
Beta coronavirus,0.1818001008509808
bat-SL-CoVZX45,0.1791652294983874
bat-SL-CoVZX21,0.1791652294983874
Bat coronavirus,0.1791652294983874
Sofosbuvir/Velpatasvir,0.1789305269082893
epidemic,0.17627787623891
MERS-CoV,0.1753917981747827
ORF1ab,0.1753917981747827
SARS-CoV antibody,0.1668917983647725
TMPRSS2,0.1668917983647725
bat SARS-CoV-like,0.1668917983647725
Bat-SL-CoVZXC21,0.1668917983647725
Bat-SL-CoVZC45,0.1668917983647725
Bat SARS-CoV,0.1668917983647725
SARS-CoV-like Coronaviruses,0.1668917983647725
N,0.1668917983647725
Nsp1,0.1668917983647725
MERS,0.1649083024862083
severe and potential fatal respiratory tract infections,0.1649083024862083
DPP4,0.1649083024862083
severe pneumonia,0.16402222442208103
nelfinavir,0.16402222442208103
ORF1a,0.16402222442208103
ORF1b,0.16402222442208103
severe respiratory diseases in afflicted human patients,0.16136957375270172
severe respiratory disease,0.16136957375270172
SARS,0.16136957375270172
neutralizing antibody m396,0.16136957375270172
monoclonal antibody,0.16136957375270172
common cold,0.15849999981001023
"severe, and often fatal, respiratory illness",0.15849999981001023
gastrointestinal diseases,0.15849999981001023
acute respiratory syndrome,0.15552222461207083
pneumonia,0.15552222461207083
severe pneumonia in patients with weaker immune system,0.15552222461207083
atypical pneumonia,0.15552222461207083
COVID-19,0.15552222461207083
death,0.15552222461207083
human respiratory disease,0.15552222461207083
severe respiratory infection,0.15552222461207083
cough,0.15552222461207083
severe humanrespiratory disease,0.15552222461207083
epidemic of acute respiratory syndrome in humans,0.15552222461207083
pitavastatin,0.15552222461207083
praziquantel,0.15552222461207083
CR3022,0.15552222461207083
perampanel,0.15552222461207083
bat SARSr-Cov,0.15552222461207083
SARS-related CoVs,0.15552222461207083
bat-like SARS coronavirus,0.15552222461207083
Bat SARS-like Coronaviruses,0.15552222461207083
bat coronavirus RaTG13,0.15552222461207083
ORF7a,0.15552222461207083
ORF10,0.15552222461207083
ORF3a,0.15552222461207083
ORF6,0.15552222461207083
ritonavir,0.15000000000000002
zopiclone,0.15000000000000002
colistin,0.15000000000000002
Bictegravir,0.15000000000000002
lopinavir,0.15000000000000002
antibody m396,0.15000000000000002
lopinavir/ritonavir,0.15000000000000002
B-M27-VME,0.15000000000000002
Prulifloxacin,0.15000000000000002
MERS-CoV-specific human monoclonal antibody m336,0.15000000000000002
eszopiclone,0.15000000000000002
trypsin,0.15000000000000002
O-acetylated sialic acid,0.15000000000000002
"For the former case, antibody response generated against the S protein, the most exposed protein of SARS-CoV, has been shown to protect from infection in mouse models (Deming et al.,  2006;  Graham  et  al.,  2012;  Yang  et  al.,  2004).",0.15000000000000002
"According to the literature,5, 6the 2019-nCoV and the SARS-CoV have a high amino acid sequence homology of the S-protein, which canresult in severe human infections.",0.15000000000000002
"Structural analysis of potential interactions between RBD of S protein from human SARS virus and ACE2 protein depicted several interaction points including four hydrophobic interactions: ACE2(Y 41 )/ RBD(Y 484 ), ACE2(L 45 )/ RBD(Y 484 ), ACE2(L 79 , M 82 )/ RBD(L 472 ), ACE2(Y 83 )/ RBD(Y 475 ), one salt-bridge: ACE2(E 329 )/ RBD(R 426 ) and one cation-π interaction: ACE2(K 353 )/ RBD(Y 491 ) ( Fig 2a, 2e ).",0.15000000000000002
By superimposing this model onto the SARS-CoV S-RBD structure (Fig.,0.15000000000000002
"b , SARS-CoV spike was engineered with silent mutations to facilitate cloning novel RBD sequences in place of the SARS spike RBD.",0.15000000000000002
Cleavage of spike protein of sars coronavirus by pro-tease factor xa is associated with viral infectivity.,0.15000000000000002
"To better understand the potential of WHCV to infect humans, the receptor-binding domain (RBD) of its spike protein was compared to those in SARS-CoVs and bat SARS-like CoVs.",0.15000000000000002
"This antibody was isolated from blood of a convalescent SARS patient, and did not compete with the antibody CR3014 for binding to recombinant S protein [ 5 ].",0.15000000000000002
"We focused specifically on the S and N proteins as these are known to induce potent and long-lived immune responses in SARS-CoV (Channappanavar et al., 2014; Deming et al., 2006; Graham et al., 2012; W. J. Liu et al., 2017; X Liu et al., 2004; J. Wang et al., 2003; Yang et al., 2004).",0.15000000000000002
"On  the  other  hand,  all  6  SARS-CoV-derived  discontinuous  B  cell  epitopes  obtained  from  the  ViPR database  (Table  7)  were  derived  from  the  S  protein.",0.15000000000000002
"Therefore, with the SARS-CoV S-RBD structure as a template, it is possible to use high-resolution homology modeling method to accurately predict the 3D model(Qian et al., 2007).",0.15000000000000002
"From this complex, we found that most of the residues that are different from those of SARS-CoV S-RBD are close to or located in the binding interface.",0.15000000000000002
"As we did for SARS-CoV spike, clade 2 and 3 spikes were codon optimized, FLAG-tagged and silent mutations were introduced to facilitate replacing their RBD with the consensus RBD from clade 1 ( figure 5a ).",0.15000000000000002
Motifs resembling amino acids 473-477 and 460-472 of the SARS-CoV spike protein are shown in red.,0.15000000000000002
"a , β-Coronaviruses, including SARS-CoV, interact with the host cell receptor via the Receptor Binding Domain (RBD) in spike (PDB: 5X5B, 2AJF) .",0.15000000000000002
It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.sequence  of  the  S-protein  is  about  75%  identical  to  that  of  the  SARS-CoV  S-protein  (Fig.,0.15000000000000002
"In addition, the N-terminus of WHCV S protein is more similar to that of SARS-CoV rather than other human coronaviruses (HKU1 and OC43) (Figure S6) that can bind to sialic acid 13 .",0.15000000000000002
"Since the receptor-binding of S-protein is the major driving force for the viral transmission to the human host cells, such a strength order supports that 2019-nCoV is able to infect the human host cells like SARS-CoV(Zhou et al., 2020).",0.15000000000000002
"3b, top panel), which contains the receptor-binding motif of the SARS-CoV S protein (F. Li, 2005).",0.15000000000000002
(f)  Crystal structure of RBD of SARS-CoV spike protein (green) (PDB 2GHV).,0.15000000000000002
"For SARS-CoV spike, silent mutations were introduced around codons 308 and 519 to form KpnI and XhoI digest sites.",0.15000000000000002
"By screening the experimentally-determined SARS-CoV-derived B cell and T cell epitopes in the immunogenic structural proteins of SARS-CoV, we identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to 2019-nCoV proteins.",0.15000000000000002
The SARS-CoV S glycoprotein: expression and functional characterization.,0.15000000000000002
The S proteins of SARS-CoV can use the endosomal cysteine proteases for S protein priming in TMPRSS2 -  cells ( 22 ).,0.15000000000000002
"Interestingly, mapping the 71 S-derived epitopes onto  the  resolved  crystal  structure  of  the  SARS-CoV  S  protein  (Fig.",0.15000000000000002
"However, this observation raised a worth-thinking issue whether the 2019-nCoV has the sameinfective mechanisms as the human SARS-CoV.The spike protein (S-protein), which is known as the multi-functional molecular machine that mediates coron-avirus entry into host cells9 is discussed to answer the question mentioned above.",0.15000000000000002
"These antibodies target the spike protein (S) of SARS-CoV and SL-CoVs, which is a type I transmembrane glycoprotein and mediates the entrance to human respiratory epithelial cells by interacting with cell surface receptor angiotensin-converting enzyme 2 (ACE2) [ 8 ].",0.15000000000000002
Potent inhibition of cell fusion mediated by  the  SARS-CoV  (left)  or  2019  nCoV  (right)  spike  (S)  glycoprotein.,0.15000000000000002
Location of identified T cell epitopes on the SARS-CoV S protein structure (PDB ID: 5XLR).,0.15000000000000002
2A and then selecting the SARS-CoV S-RBD structure (PDB 2AJF) as the modeling template.,0.15000000000000002
"Due to the high amino acid sequence homology of the S protein in 2019-nCoV and the SARS virus which can cause severe human infection, we analyzed the structural similarity of this protein in various viruses.",0.15000000000000002
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.,0.15000000000000002
The PDB files of the predicted protein structures were displayed and compared with the crystal structures of SARS-CoV spike RBD (PDB 2GHV) 37  and the crystal of structure of SARS-CoV spike RBD complexed with human ACE2 (PDB 2AJF) 12 .,0.15000000000000002
Set of SARS-CoV-derived S and N protein T cell epitopes that maximize estimated population coverage globally.,0.15000000000000002
"Interestingly, within the backbone of SARS-CoV spike, cell entry of 2019-nCoV was similar to the other clade 1 spikes tested, including SARS-CoV.",0.15000000000000002
"A straightforward reference-sequence-based comparison indeed confirmed this, showing that the M, N, and  E  proteins  of  2019-nCoV  and  SARS-CoV  have  over  90%  genetic  similarity,  while  that  of  the  S protein was notably reduced (but still high) (Fig.",0.15000000000000002
"For comparison, about 50 residues that are different from those of SARS-CoV S-RBD are shown as sphere models (see also Fig.",0.15000000000000002
SARS-CoV-derived linear B cell epitopes (total 56 epitopes) from S and N proteins that are identical in 2019-nCoV.,0.15000000000000002
Location of SARS-CoV-derived B cell epitopes on the SARS-CoV S protein structure (PDB ID: 5XLR).,0.15000000000000002
"By screening the experimentally-determined SARS-CoV-derived B cell and T cell epitopes in the immunogenic structural proteins of SARS-CoV, we identified a set of B cell and T cell epitopes derived from the spike (S) and nucleocapsid (N) proteins that map identically to 2019-nCoV  proteins.",0.15000000000000002
"IEDB ID  910052 77444 77442 SARS-CoV S protein residues1,2 G446, P462, D463, Y475 T359, T363, K365, K390, G391, D392, R395, R426, Y436, G482, Y484, T485, T486, T487, G488, I489, G490, Y491, Q492, Y494 R426, S432, T433, Y436, N437, K439, Y440, Y442, P469, P470, A471, L472, N473, C474, Y475, W476, L478, N479, D480, Y481, G482, Y484, T485, T486, T487, G488, I489, Y491, Q492 1 Residues are numbered according to the SARS-CoV S protein reference sequence, accession ID: NP_828851.1.",0.15000000000000002
Cartoon model of the structural superposition between the homology model of the 2019-nCoV in blue and the spike glycoprotein of SARS Coronavirus (PDB code 6acc.1) in orange.,0.15000000000000002
"Pairwise  sequence  alignment  of  the  reference  sequences  of  the  S  proteins  of SARS-CoV  and  2019-nCoV  (accession  ID:  NP_828851.1  and  YP_009724390.1,  respectively).",0.15000000000000002
Structure of SARS coronavirus spike receptor-binding domain complexed with receptor.,0.15000000000000002
"Mapping the residues of the B cell epitopes onto the available structure of the SARS-CoV S protein revealed that the linear epitopes (Table 6) map to seemingly less-exposed regions, away from the most exposed region, the “spike head” (Fig.",0.15000000000000002
The ancestors of both human SARS-CoV and 2019-nCoV share a common ancestor.,0.15000000000000002
"Sampling additional animals at the market and wildlife inthe surrounding area may help elucidate whether intermediary species were involved or not, as waspossible with the SARS-CoV.Viral outbreaks like nCoV-2019 demand timely analysis of genomic sequences to guide theresearch in the right direction.",0.15000000000000002
"However, the application of DTI prediction in the present study may be useful to control unexpected and rapidly spreading infections such SARS-CoV, MERS-CoV, and 2019-nCoV at the frontline of the disease control until better therapeutic measures are developed.",0.15000000000000002
"Comparing with that of SARS-CoV, the S-RBD sequence of 2019-nCoV S-protein is very conserved, implying that ACE2 is the specific receptor for this virus to bind to the human host cells(Lu et al., 2020; Xu et al., 2020).",0.15000000000000002
"Moreover,  fusion  proteins potently  neutralized  SARS-CoV  and  2019-nCoV  in  vitro.",0.15000000000000002
"Moreover, fusion proteins potently neutralized SARS-CoV and 2019-nCoV in vitro.",0.15000000000000002
Based  on  the  pairwise  alignment  between  the SARS-CoV and 2019-nCoV reference sequences (Supplementary Fig.,0.15000000000000002
From SARS-CoV to Wuhan 2019-nCoV Outbreak: Similarity of Early Epidemic and Predictionof Future Trends.,0.15000000000000002
"Conclusion To summarize, motivated by the high genetic similarity between the structural proteins of SARS-CoV and 2019-nCoV, we analysed the available experimentally-determined SARS-CoV-derived T cell and B cell epitopes and identified sets of epitopes that map identically to 2019-nCoV proteins.",0.15000000000000002
We observe that few residues of the discontinuous epitopes that lie within the receptor-binding motif are identical within SARS-CoV and 2019-nCoV (Fig.,0.15000000000000002
the presence of an alpha-helix on the SARS-CoV and not present on the 2019 n-CoV structure and e positional difference of the beta-sheets.,0.15000000000000002
Alignment of the nCoV-2019 PLpro domain with the X-ray structure ofthe closely related SARS-CoV PLpro domain in complex with ubiquitin.,0.15000000000000002
"We used the publicly available software PASTA v1.6.4 (Mirarab et al., 2015) to construct a maximum-likelihood phylogenetic tree of each structural protein using the available  sequence  data  of  SARS-CoV,  MERS-CoV,  and  2019-nCoV.",0.15000000000000002
The residues that are differentbetween SARS-CoV PLpro and nCoV-2019 PLpro are highlighted as sticks.,0.15000000000000002
This discrepancy of effective  R  between SARS-CoV and 2019-nCoV may be partially explained by transmission patterns.,0.15000000000000002
(B) Potentialinteractions between L1803 of SARS-CoV PLpro and nCoV-2019 PLpro with residueA46 of ubiquitin.,0.15000000000000002
"Given  the  close  genetic  similarity  between  the  structural  proteins  of  SARS-CoV  and  2019-nCoV proteins, we attempted to leverage immunological studies of the structural proteins of SARS-CoV to potentially aid vaccine development for 2019-nCoV.",0.15000000000000002
"Here we developed an approach to rapidly screen lineage B betacoronaviruses, such as SARS-CoV and the recent 2019-nCoV, for receptor usage and their ability to infect cell types from different species.",0.15000000000000002
Both  fusion proteins has high affinity binding to the receptor-binding domain (RBD) of SARS-CoV and 2019-nCoV  and  exerted  desired  pharmacological  properties.,0.15000000000000002
"Four lines at the bottom were used as references, especially the SARS-CoV (accession  NC_004718 ), to show the correspondence sites of amino acid residues between 2019-nCoV and the known  Betacoronavirus .",0.15000000000000002
SARS-S und 2019-nCoV-S share ~76% amino acid identity.,0.15000000000000002
The residues that are 606 different between SARS-CoV PLpro and nCoV-2019 PLpro are highlighted as sticks.,0.15000000000000002
Both fusion proteins has high affinity binding to the receptor-binding domain (RBD) of SARS-CoV and 2019-nCoV and exerted desired pharmacological properties.,0.15000000000000002
We want to point out  that  all  the  docking  simulations  for  SARS-CoV  and  2019-nCoV  use  the  same  protocols  and  a consistent all-atom energy function.,0.15000000000000002
We used the available SARS-CoV-derived experimentally-determined epitope data (see Materials and Methods) and searched to identify T cell and B cell epitopes that were identical—and hence potentially cross-reactive—across SARS-CoV and 2019-nCoV.,0.15000000000000002
"The main protease of SARS-CoV is essential for the life cycle of the virus, which showed 96.1% of similarity with the main proteaseof 2019-nCoV, is considered to be an attractive target for drug development.",0.15000000000000002
By aligning the X-ray structure of the 244 PLpro domains of SARS-CoV bound to ubiquitin (17) with the sequence of nCoV-2019 PLpro 245 (Fig.,0.15000000000000002
Alignment of the nCoV-2019 PLpro domain with the X-ray structure of the closely 599 related SARS-CoV PLpro domain in complex with ubiquitin.,0.15000000000000002
"Here, by analysing available experimentally-determined SARS-CoV-derived B cell epitopes (both linear and discontinuous) and T cell epitopes, we identify and report those that are completely identical and comprise no mutation in the available 2019-nCoV sequences (as of 29 January 2020).",0.15000000000000002
"The copyright holder for thispreprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.It is made available under a CC-BY-NC 4.0 International license.Protein  Conservation  within  2019-nCoV  and  between  other  beta-coronaviridae We  performed  a  cross-species  analysis  for  all  proteins  encoded  by  the  2019-nCoV  and  its  relatives.",0.15000000000000002
"Hexagonal points that are closertogether and less dispersed as seen in (b) are more strongly correlated and have less deviation.2019−nCoV Vs Alphacoronavirus, k=7, rho=0.7, p < 1e−05log(count)02468e−04surivanorocahpAl6e−044e−042e−040e+000e+002e−044e−042019−nCoV6e−042019−nCoV Vs Betacoronavirus, k=7, rho=0.74, p < 1e−05log(count)02466e−04surivanorocateB4e−042e−040e+000e+002e−044e−042019−nCoV6e−042019−nCoV Vs Gammacoronavirus, k=7, rho=0.63, p < 1e−05log(count)0246surivanorocammaG6e−044e−042e−040e+000e+002e−044e−046e−042019−nCoV2019−nCoV Vs Deltacoronavirus, k=7, rho=0.6, p < 1e−05log(count)02464e−042e−04surivanorocatleD0e+000e+002e−044e−046e−042019−nCoVbioRxiv preprint first posted online Feb. 4, 2020; The copyright holder forthis preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in http://dx.doi.org/10.1101/2020.02.03.932350doi: .",0.15000000000000002
"Discussion Our results highlight a high level of conservation within 2019-nCoV genomes sequenced so far, and a clear origin from other beta-CoVs, specifically BCoVs, SARS and MERS.",0.15000000000000002
"From our machine learning-based alignment-free analyses using MLDSP-GUI, we corroborate the current hypothesis of a bat origin and classify 2019-nCoV as Sarbecovirus, within Betacoronavirus.",0.15000000000000002
"The 2019-nCoV showed thehighest k-mer frequency correlation to Betacoronavirus at k = 7 (Table 4), which is consistent with theML-DSP results in Test-3 (Table 2).",0.15000000000000002
Test-5 and Test-6(see Table 3) are designed to verify that 2019-nCoV sequences can be differentiated from the knownspecies in the Betacoronavirus genus.,0.15000000000000002
"The 2019-nCoV viruswas compared to all genera under the Coronaviridae family and the k-mer frequencies showed thestrongest correlation to the genus Betacoronavirus, and more speciﬁcally Sarbecovirus.",0.15000000000000002
The closeness of 2019-nCoV with the sequences from theBetacoronavirus genus (especially sub-genus Sarbecovirus) is further veriﬁed using the quantitativeanalyses based on the Spearman’s rank correlation coefﬁcient tests.Spearman’s rank correlation coefﬁcient [57–60] tests use the frequencies of oligonucleotidesegments and compares them to the total number of segments at different k-mer lengths to measurethe degree of correlation between two sets of genomic sequences.,0.15000000000000002
"All trained classiﬁcation modelscorrectly predict the 2019-nCoV as Betacoronavirus, see Table 2.",0.15000000000000002
"From our machine learning-basedalignment-free analyses using MLDSP-GUI, we corroborate the current hypothesis of a bat originand classify 2019-nCoV as Sarbecovirus, within Betacoronavirus.Keywords: Machine Learning; Digital Signal Processing; Genomic signature; Alignment-freesequence analysis; Chaos Game Representation; Betacoronavirus; 2019-nCoV; Wuhan1.",0.15000000000000002
"From our machine learning-based alignment-freeanalyses using MLDSP-GUI, we corroborate the current hypothesis of a bat origin for 2019-nCoV andclassify 2019-nCoV as sub-genus Sarbecovirus, within Betacoronavirus.5.",0.15000000000000002
Comparison of the similarity of structural proteins of 2019-nCoV with the corresponding proteins of SARS-CoV and MERS-CoV.,0.15000000000000002
"We reported that the mean  R 0  of 2019-nCoV is likely to be from 2.24 (8-fold) to 3.58 (2-fold), and it is largely in the range of those of SARS, i.e., 2-5 [ 11 ,  18 ,  20 ], and MERS, i.e., 2.7-3.9 [ 12 ].",0.15000000000000002
"However, using SIs of SARS and MERS as approximation could provide an insight to the transmission potential of 2019-nCoV at the early stage of the outbreak.",0.15000000000000002
"Phylogenetic tree of all the 2019-nCov sequences available at 02-Feb-2020 (branches shown in blue),  plus  six  Bat  coronavirus  sequences  (default  black,  as  they  are  split  in  multiple  taxa),  six  Human SARS  (green)  and  2  MERS  (orange).",0.15000000000000002
"Compared with SARS and MERS,  R 0  of 2019-nCov was similar to SARS ( R 0 =4.91) in Beijing, China, in 2003 [ 6 ] and MERS in Jeddah (3.5-6.7) and Riyadh (2.0-2.8), Kingdom of Saudi Arabia, in 2014 [ 7 ].",0.15000000000000002
"The similarity between 2019-nCov and MERS-CoV, on the other hand, was substantially lower for all proteins (Fig.",0.15000000000000002
"In this work, we employed the SIs of SARS and MERS as approximations to that of 2019-nCoV.",0.15000000000000002
"The prediction results warn us that the 2019-nCoV have strong potential of infecting human similar to SARS, Bat SARS-like Coronaviruses and MERS.",0.15000000000000002
"To evaluate whether 2019-nCoVs are close to SARS, Bat SARS-like Coronaviruses and MERS genetically, we built a phylogenetic tree with the whole genome sequences of all the Coronaviruses utilized above, which showed that 2019-nCoVs have a closer phylogenetic relationship with SARS and Bat SARS-like Coronaviruses than other Coronaviruses (as shown in  Fig.",0.15000000000000002
"Our prediction suggests that 2019-nCoV has close infectivity with other human coronaviruses, especially the severe acute respiratory syndrome coronavirus (SARS-CoV), Bat SARS-like Coronaviruses and the Middle East respiratory syndrome coronavirus (MERS-CoV).",0.15000000000000002
"Results and Discussion Structural proteins of 2019-nCoV are genetically similar to SARS-CoV, but not to MERS-CoV.",0.15000000000000002
"Since the transmission chain of 2019-nCoV remains unclear, we adopted the SI information from SARS and MERS, which share the similar pathogen as 2019-nCoV.",0.15000000000000002
"The time window of the reporting rate increase accounts for the official report on improving the 2019-nCoV surveillance released by the Chinese government by the end of January 21 [ 10 ], which also coincides with the average of the incubation periods of two other well-known coronavirus diseases, i.e., the middle east respiratory syndrome (MERS) and the severe acute respiratory syndrome (SARS), i.e., 5 days [ 11 – 13 ].",0.15000000000000002
"Consistent with the phylogenetic tree data, 2019-nCoV did not align well with the MERS and IBV virus ( Fig S1 ).",0.15000000000000002
"In this study, we performed in-depth genetic analysis of 2019-nCoV and generated data which provide timely and valuable insight into the potential origin of this virus, its ability to cause human infection, and its genetic relatedness with SARS and MERS.",0.15000000000000002
(a) Percentage genetic similarity of the individual structural proteins of 2019-nCoV with those of SARS-CoV and MERS-CoV.,0.15000000000000002
"Sequence analysis revealed that 2019-nCoV clusters with SARS-CoV-related viruses from bats (SARSr-CoV), of which some but not all can use ACE2 for host cell entry ( Fig.",0.15000000000000002
"[13] Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCov.",0.15000000000000002
"Finally, based on our results, it 160 should be expected and worth to test if ACE2 targeting or SARS-CoV targeting drugs 161 can be used for nCoV-2019 patients.",0.15000000000000002
"Further structural similarity analysis showed and conﬁrmed that the S-proteinof 2019-nCoV uses the same human cell receptor angiotensin-converting enzyme 2 (ACE2) as SARS-CoV.4, 10Therefore, similar approaches can be applied to prevent the S-protein binding with the receptor ACE2.S-protein is one of the four proteins in coronavirus, which can be cleaved by a host cell furin-like protease(non-structural protein in coronavirus) into two functional units, S1 and S2.",0.15000000000000002
"Interactions between ACE2 with RBD of human SARS virus (a), highly similar bat SARS like coronavirus, CoV-W1V1 that can infect human (b), new type of coronavirus, 2019-nCoV (c), bat SARS like coronavirus CoV SL-CoVZXC21 and bat coronavirus HKU3-1 (d) are shown.",0.15000000000000002
"Very recently report had suggested that novel CoV would use the same cell entry receptor, ACE2, as the SARS-CoV.",0.15000000000000002
"Our results show that the human receptor-binding affinity of 2019-nCoV is about 73% of that of SARS-CoV, implying that 2019-nCoV is able to bind to ACE2, and thereby infects the human host cells like SARS-CoV.",0.15000000000000002
"Potent neutralization of 2019 novel coronavirus by recombinant ACE2-Ig Changhai Lei1, Wenyan Fu2, Kewen Qian3, Tian Li1,3, Sheng Zhang4, Min Ding5, and Shi Hu1, 3*  1  Department  of  Biophysics,  College  of  Basic  Medical  Sciences,  Second  Military  Medical University, Shanghai 200433, China.",0.15000000000000002
"Thus, one can expect that 2019-nCoV targets the same cells as SARS-CoV and that the previously documented modest ACE2 expression in the upper respiratory tract ( 23 ,  28 ) might limit 2019-nCoV transmissibility.",0.15000000000000002
"The same as severe acute respiratory syndrome coronavirus (SARS-CoV), 2019-nCov enters into host cells via cell receptor angiotensin converting enzyme II (ACE2).",0.15000000000000002
"With regard to human HeLa cells, expressing ACE2 from human, civet, and Chinese horseshoe bat can help many kinds of SARSr-CoV, including 2019-nCov, to enter into the cells, indicating the important role of ACE2 in cellular entry [ 10 ,  27 - 29 ].",0.15000000000000002
"In order to dissect the ACE2-expressing cell composition and proportion and explore a potential route of the 2019-nCov infection in digestive system infection, 4 datasets with single-cell transcriptomes of lung, esophagus, gastric, ileum and colon were analyzed.",0.15000000000000002
"( C ) 293T cells transiently expressing ACE2 of human (dark blue) or bat (light blue) origin, human APN (purple) or hDPP4 (green) were inoculated with pseudotyped VSV harboring VSV-G, SARS-S, 2019-nCoV-S, MERS-S or 229E-S. At 16 h postinoculation, pseudotype entry was analyzed.",0.15000000000000002
"Angiotensin-converting  enzyme  2  (ACE2),  a  carboxypeptidase  that  potently  degrades angiotensin  II  to  angiotensin  1–7,  has  been  identified  as  a  functional  receptor  for SARS-CoV1 and a potent receptor for 2019-nCoV2.",0.15000000000000002
"Previous RNA-seq data in the human protein atlas (HPA) database [10] shown relatively low expression of ACE2 in liver, as well as lung, which is the main target organ for 2019-nCoV and  SARS.",0.15000000000000002
"In combination withthe identiﬁcation that the angiotensin converting enzyme 2 (ACE2) protein is a receptor for 2019-nCoV,as it is for SARS and other Sarbecovirus strains, the hypothesis that 2019-nCoV originated from bats isdeemed very likely [12,34,36,39,42–45].All analyses performed thus far have been alignment-based and rely on the annotations ofthe viral genes.",0.15000000000000002
"Since  ACE2  is  capable  in  mediating  2019-nCoV  and  SARS  infections,  its expression pattern reveals possibility for direct infection of cholangiocytes by 2019-nCoV and SARS.",0.15000000000000002
"2019-nCoV is closely related to Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), and was proposed to share the same receptor, angiotensin converting enzyme 2 (ACE2), with SARS [2-4].",0.15000000000000002
"ACE2,  the  host  cell  receptor  for  severe  acute  respiratory syndrome  coronavirus  (SARS),  has  recently  been  demonstrated  in  mediating  2019-nCoV infection.",0.15000000000000002
356  357 Examination of ACE2 receptor for nCoV-2019 infection.,0.15000000000000002
"It has been reported recently  that  2019-nCoV  is  able  to  bind  to  the  same  receptor  as  SARS-CoV  (ACE2)  for  cell  entry,      7 bioRxiv preprint first posted online Feb. 4, 2020; The copyright holder forthis preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in http://dx.doi.org/10.1101/2020.02.03.933226doi: .",0.15000000000000002
These  data  suggest  that both  ACE2-Ig  and mACE2-Ig exhibit potent inhibitory activity against SARS CoV and 2019 nCOV.,0.15000000000000002
"Based on the receptor function of ACE2 for coronavirus, we hypothesis that ACE2 fusion  protein  may  have  neutralization  potential  for  coronavirus,  especially  the 2019-nCoV.",0.15000000000000002
"Single-cell RNA expression proﬁling of ACE2, the putative receptor of Wuhan 2019-nCov.44.",0.15000000000000002
"In sum, the high similarities of amino acid sequences and predicted protein structure between WHCV and SARS-CoV RBD domains suggest that WHCV may efficiently use human ACE2 as a cellular entry receptor, perhaps facilitating human-to-human transmission 10 ,  14 – 15 .",0.15000000000000002
"ACE2, the host cell receptor for severe acute respiratory syndrome coronavirus (SARS), has recently been demonstrated in mediating 2019-nCoV infection.",0.15000000000000002
"In this study, we found the high expressions of ACE2, the cell entry receptor of 2019-nCov, in the lung AT2 cells, esophagus upper and stratified epithelial cells and absorptive enterocytes from ileum and colon, indicating that not only respiratory system but also digestive system are potential routes of infection.",0.15000000000000002
"The human ACE2 receptor has also been identiﬁed as the potentialreceptor for 2019-nCoV and represents a potential target for treatment [42,43].MLDSP-GUI is an ultra-fast, alignment-free method as is evidenced by the time-performance ofMLDSP-GUI for Test-1 to Test-6 given in Figure 7.",0.15000000000000002
"However, it is unknown whether 2019-nCoV-S like SARS-S employs ACE2 and TMPRSS2 for host cell entry.",0.15000000000000002
"Very  recently  report  had  suggested  that  novel  CoV  would use  the  same  cell  entry  receptor,  ACE2,  as  the  SARS-CoV.",0.15000000000000002
"Analysis of the receptor binding motif (RBM), a portion of the receptor binding domain (RBD) that makes contact with ACE2, revealed that most amino acid residues essential for ACE2 binding were conserved in 2019-nCoV-S but not in the S proteins of SARSr-CoV previously found not to use ACE2 for entry ( Fig.",0.15000000000000002
"It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.potential mechanism of infection and direct damage of bile ducts by virus using ACE2 as host cell receptors, such as 2019-nCoV and SARS.",0.15000000000000002
"In addition, due to the high expression of cell receptor ACE2 in esophagus upper and stratified epithelial cells and absorptive enterocytes from ileum and colon, we suppose that digestive system can be invaded by 2019-nCov and serve as a route of infection.",0.15000000000000002
"After we identified that ACE2 fusion proteins binds to the RBDs with high affinity, we next sought to test the inhibitory activity of ACE2 fusion proteins against 2019-nCoV and  compare  it  with  that  against  SARS-CoV,  by  using  viruses  pseudotyped  with  the  S glycoprotein  of  SARS-CoV and 2019-nCoV.",0.15000000000000002
We also demonstrate how different lineage B viruses can recombine to gain entry into human cells and confirm that human ACE2 is the receptor for the recently emerging 2019-nCoV.,0.15000000000000002
"Indeed, recent experimental evidences also supported that ACE2 is the human receptor of 2019-nCoV(Zhou  et  al.,  2020).",0.15000000000000002
ACE2-Ig  potently  neutralizes  viruses  pseudotyped  with  S  glycoproteins from the SARS CoV and 2019 nCoV.,0.15000000000000002
"To determine whether nCoV-2019 also use ACE2 as a cellular entry receptor, 141 we conducted virus infectivity studies using HeLa cells expressing or not expressing 142 ACE2 proteins from humans, Chinese horseshoe bats, civet, pig, and mouse.",0.15000000000000002
"The RBD for 2019-nCoV has residues and motifs found in all 3 clades but forms a distinct clade, so we tested it for receptor usage and observed entry only with human ACE2 but not other known coronavirus receptors ( figure 3d ).",0.15000000000000002
"To  investigate  the  possible  cause  of  2019-nCoV  patient  liver  damage,  we  used  both published  liver  cell  atlas  data  and  an  independent  unpublished  data  generated  in-house  to evaluate ACE2 gene expression in all cell types in healthy livers.",0.15000000000000002
"To  sum  up,  our  data  investigate  the  therapeutic  potential  of  ACE2  based  strategies against 2019-nCoV which could be used alone or in combination.",0.15000000000000002
"Thus, ACE2 plays an vital role in the 2019-nCoV infection.",0.15000000000000002
"The finding that 2019-nCoV-S and SARS-S use the same receptor, ACE2, for entry into target cells has important implications for our understanding of 2019-nCoV transmissibility and pathogenesis.",0.15000000000000002
( B ) Alignment of the receptor binding motif of SARS-S with corresponding sequences of bat-associated betacoronavirus S proteins that are able or unable to use ACE2 as cellular receptor reveals that 2019-nCoV possesses amino acid residues crucial for ACE2 binding.,0.15000000000000002
"We 143 show that nCoV-2019 is able to use all but mouse ACE2 as an entry receptor in the 144 ACE2-expressing cells, but not cells without ACE2, indicating which is likely the cell bioRxiv preprint first posted online Jan. 23, 2020; The copyright holder forthis preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in http://dx.doi.org/10.1101/2020.01.22.914952doi: .",0.15000000000000002
The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells.,0.15000000000000002
Our data  shows  that  Both  SARS-CoV  and 2019-nCoV viruses were potently neutralized by ACE2-Ig and mACE2-Ig.,0.15000000000000002
"2019-nCoV can enter into ACE2-expressing cells, but not into cells without ACE2 or cells with other coronavirus receptors, such as aminopeptidase N and dipeptidyl peptidase[ 10 ].",0.15000000000000002
"2C ), indicating that 2019-nCoV-S like SARS-S uses ACE2 for cellular entry.",0.15000000000000002
"These finding suggests 2019-nCoV is capable of using human ACE2 as efficiently as SARS-CoV, which may help explain the human-to-human transmissibility of this virus.",0.15000000000000002
"A recent study revealed that similar to SARS-CoV and MERS-CoV, ACE2 was the cell entry receptor for 2019-nCov[ 10 ].",0.15000000000000002
"The IC50 of SARS-CoV  and  2019-nCoV  viruses  neutralized  by  ACE2-Ig  were  0.8  and  0.1 g/ml, respectively.",0.15000000000000002
"In addition, the enteric symptoms of 2019-nCov may be associated with the invaded ACE2-expressing enterocytes.",0.15000000000000002
"The short turnaround time for our approach allowed us to test the receptor usage of all published, unique RBD sequences in lineage B, and also rapidly confirm the ACE2 receptor usage of the 2019-nCoV spike, which emerged in China in January 2020 as our study was ongoing.",0.15000000000000002
"Here, we demonstrate that 2019-nCoV-S uses the SARS-coronavirus receptor, ACE2, for entry and the cellular protease TMPRSS2 for 2019-nCoV-S priming.",0.15000000000000002
"It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.Specific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection Xiaoqiang Chai1,2*, Longfei Hu3*, Yan Zhang3*, Weiyu Han1,2*, Zhou Lu1,2, Aiwu Ke1,2, Jian Zhou1,2, Guoming Shi1,2, Nan Fang3, Jia Fan1,2, Jiabin Cai1,2#, Jue Fan3#, Fei Lan1,2# 1.",0.15000000000000002
"In 2019-nCoV infection, a metallopeptidase, angiotensin converting enzyme II (ACE2) is proved to be the cell receptor, the same as SARS-CoV infection[ 9 - 11 ].",0.15000000000000002
"[3] Hoffmann M, Kleine-Weber H, Krueger N, Mueller MA, Drosten C, Poehlmann S. The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells.",0.15000000000000002
"In order to explore the infection routes of 2019-nCov and the roles of ACE2 in digestive system infection, we identified the ACE2-expressing cell composition and proportion in normal human lung and gastrointestinal system by single-cell transcriptomes based on the public databases.",0.15000000000000002
"Consequently,  it  becomes  very  interesting  to  characterize  the  human receptor-binding capability of 2019-nCoV by analyzing the S-protein interactions with ACE2, in order to assess its potential for the human-to-human transmission.",0.15000000000000002
"Three bat SARS-like CoVs, which could efficiently utilize the human ACE2 as receptor, had an RBD sequence of similar size to SARS-CoV, and WHCV contains a single Val 470 insertion.",0.15000000000000002
"These results indicate that ACE2 could be the potential receptor for the new coronavirus, and that the expressed 2019-nCoV RBD protein is functional [ 2 ].",0.15000000000000002
"It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.Introduction   Coronaviruses (CoV) are positive-stranded enveloped RNA viruses belonging to the order Nidovirales, and  are  classified  into  four  genera:  a,  b,  d  and  g. Two  of  the  b-CoVs,  the  server  acute  respiratory syndrome  CoV  (SARS-CoV)  and  the  Middle  East  respiratory  syndrome  CoV  (MERS-CoV),  have caused  serious  epidemics.",0.15000000000000002
This could be due to the relatively high identity (73%) of RBD in 2019-nCoV and SARS-CoV ( Figure 1c ).,0.15000000000000002
"By  sampling  a  large  number  of thermodynamically  probable  binding  conformations  with  Monte  Carlo  algorithm,  this  approach successfully  identified  the  experimental  complex  structure  as  the  lowest-energy  receptor-binding conformations,  and  hence  established  an  experiment-based  strength  reference  for  evaluating  the receptor-binding affinity of 2019-nCoV via comparison with SARS-CoV.",0.15000000000000002
(A) Amino-acid sequence alignment of 2019-CoV and SARS-CoV S-RBDs with an identity of 72.8%.,0.15000000000000002
"A novel coronavirus, 2019-nCoV, which is closely related to SARS-CoV, was detected in patients and is believed to be the etiologic agent of the new lung disease ( 10 ).",0.15000000000000002
The RBD of 2019-nCoV differ largely from the SARS-CoV at the C-terminus residues ( Figure 1c ).,0.15000000000000002
"The  R  values of 2019-nCoV were 2.90 (95%CI: 2.32-3.63) and 2.92 (95%CI: 2.28-3.67) estimated using EG and ML respectively, while the corresponding  R  values of SARS-CoV were 1.77 (95%CI: 1.37-2.27) and 1.85 (95%CI: 1.32-2.49).",0.15000000000000002
"In phylogenies of the fragment nt 1 to 1029 and nt 1652 to the end of the sequence, WHCV was most closely related to Bat-SL-CoVZC45 and Bat-SL-CoVZXC21, whereas in the region nt 1030 to 1651 (the RBD region) WHCV grouped with SARS CoV and bat SARS-like CoVs (WIV1 and RsSHC014) that are capable of direct human transmission 14 ,  17 .",0.15000000000000002
"In addition, the WHCV RBD was only one amino acid longer than the SARS-CoV RBD ( Figure 4a ).",0.15000000000000002
"Although we know quite a little about 2019-nCoV, it is fortunate that the sequence identity of the 2019-nCoV protease and that of severe acute respiratory syndrome virus (SARS-CoV) is as high as 96.1%.",0.15000000000000002
Cartoon model of the structural superposition between the homology model of the 2019-nCoV in blue and the Nucleocapsid protein of SARS Coronavirus (PDB code 2jw8.1) in orange.,0.15000000000000002
"It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.Sequence alignment of S1-proteins has revealed a sequence identity of about 75% between that of 2019-nCoV and those of several other CoVs including SARS-CoV(Zhou et al., 2020).",0.15000000000000002
"Preliminary studies suggest that the 2019-nCoV is quite similar to SARS-CoV based on the  full-length  genome  phylogenetic  analysis  (Lu  et  al.,  2020;  Zhou  et  al.,  2020),  and  the  putatively similar cell entry mechanism and human cell receptor usage (Hoffmann et al., 2020; Letko & Munster, 2020; Zhou et al., 2020).",0.15000000000000002
1D) also appear to 252 be preserved with M1812 of nCoV-2019 and SARS-CoV PLpro (Fig.,0.15000000000000002
1B) are lost in nCoV-2019 and SARS-CoV (Fig.,0.15000000000000002
"Moreover, considering the high sequence identity betweenviral proteases of 2019-nCoV and SARS-CoV, seeking protease inhibitors to treat respiratory diseases inducedby SARS and this novel pneumonia will be our ﬁrst choice.Viral proteases are common targets in dealing with human viruses such as the HIV virus and hepatitis Cvirus.",0.15000000000000002
"In the study, we examined the incubation period, reproductive number ( R ) and the period from onset of symptoms to isolation using confirmed 2019-nCoV cases data, and further compared them with that of SARS-CoV.",0.15000000000000002
"To the end, we first generated an initial model for the 2019-nCoV S-RBD via SWISS-MDOEL server at https://swissmodel.expasy.org, with the experimental S-RBD structure of SARS-CoV as the template (PDB 2AJF).",0.15000000000000002
"By sampling a large number of thermodynamically probable binding conformations with Monte Carlo algorithm, this approach successfully identified the experimental complex structure as the lowest-energy receptor-binding conformations, and hence established an experiment-based strength reference for evaluating the receptor-binding affinity of 2019-nCoV via comparison with SARS-CoV.",0.15000000000000002
One sentence summary  The novel 2019 coronavirus and the SARS-coronavirus share central biological properties which can guide risk assessment and intervention.,0.15000000000000002
"In this study, we sought to gain insights for vaccine design against 2019-nCoV by considering the high genetic similarity between 2019-nCoV and the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), and leveraging existing immunological studies of SARS-CoV.",0.15000000000000002
"Considering the highsequence identity between viral proteases of 2019-nCoV and SARS-CoV, we take the protease of SARS-CoV asthe input target in ChEMBL and a total 115 ChEMBL IDs of the target can be found.",0.15000000000000002
1C) are likely preserved 250 with the substitution of E1772 in nCoV-2019 and SARS-CoV PLpro (Fig.,0.15000000000000002
"The  2019-nCoV  has  been  observed  to  be  close  to  SARS-CoV—much  more  so  than  MERS-CoV—based on full-length genome phylogenetic analysis (Lu et al., 2020; Zhou et al., 2020).",0.15000000000000002
"Our results show that this binding affinity is about 73% of that of SARS-CoV, supporting that 2019-nCoV may cause human transmission similar to that of SARS-CoV.",0.15000000000000002
"At present, it is unknown whether the sequence similarities between 2019-nCoV and SARS-CoV translate into similar biological properties, including pandemic potential ( 13 ).",0.15000000000000002
"However, the seven conserved replicase domains in ORF1ab 79 that were used for CoV species classification, are 94.6% aa sequence identical 80 between nCoV-2019 and SARS-CoV, implying the two belong to same species 81 (Extended Data Table 3).",0.15000000000000002
"Although 2019-nCoV is significantly different from SARS-CoV, which breakout in Beijing 17 years before [ 3 ], the sequence identity between themis as high as 79.5%.",0.15000000000000002
"Our results reveal important commonalities between 2019-nCoV and SARS-coronavirus infection, which might translate into similar transmissibility and disease pathogenesis.",0.15000000000000002
"It  is  noteworthy  that  while  MERS-CoV  is  the  more  recent coronavirus to have infected humans, and is comparatively more recurrent (causing outbreaks in 2012, 2015, and 2018) (https://www.who.int/emergencies/mers-cov/en/), 2019-nCoV is closer to the SARS-CoV which has not been observed since 2004.",0.15000000000000002
"2019-nCoV  strains  (n=48  including  one  bat  strain)  from  current outbreak,  SARS-like-CoV  (n=2),  SARS-CoV  (n=8)  and  MERS-CoV  (n=10)  viruses  are colored in  red,  orange,  yellow  and  green,  respectively.",0.15000000000000002
"In addition to these ORFs regions that are shared by all members of the subgenus  Sarbecovirus , WHCV is similar to SARS-CoV in that it carries a predicted ORF8 gene (366 nt in length) located between the M and N ORF genes.",0.15000000000000002
"Clearly, 2019-nCoV has a strong genetic relationship with SARS-CoV.",0.15000000000000002
"In this study, we sought to gain insights for vaccine design against 2019-nCoV by considering the high genetic similarity between 2019-nCoV and the  Severe  Acute  Respiratory  Syndrome  coronavirus  (SARS-CoV),  and  leveraging  existing immunological studies of SARS-CoV.",0.15000000000000002
These features can explain the 2019-nCoV zoonotic transmission and its initial lower severity than SARS epidemic.,0.15000000000000002
Our analysis suggests that the early pattern of human-to-human transmission 2019-nCoV is reminiscent of SARS-CoV emergence in 2002. International collaboration and coordination will be crucial in order to contain the spread of 2019-nCoV.,0.15000000000000002
"However, the docking sampling for a large number of thermodynamically probable conformations did not find any binding conformation with an energy score lower than that of the lowest-energy conformation of SARS-CoV derived from experimentally determined structure, offering molecular evidence that the receptor-binding ability of 2019-nCoV is less than that of SARS-CoV.",0.15000000000000002
"Phylogenetic analysis suggested that WHCV represents a novel virus within genus  Betacoronavirus  (subgenus  Sarbecovirus ) and hence that exhibits some genomic and phylogenetic similarity to SARS-CoV 1 , particularly in the RBD.",0.15000000000000002
We observe a decreasing trend of the period from onset to isolation and  R  values of both 2019-nCoV and SARS-CoV.,0.15000000000000002
"We estimate this probability under the assumption that the transmissibility of the 2019-nCoV is similar to that of the SARS coronavirus, and then go on to consider the effect of shortening the mean time from symptom onset to hospitalisation.",0.15000000000000002
"Full-length genome analysis of 2019-nCoV patient samples revealed 79.5% and 96% sequence identities to SARS-CoV and a bat SARSr-Cov (severe acute respiratory syndrome-related CoV), respectively; however, sequences of the seven conserved viral replicase domains in ORF1ab show 94.6% identity between 2019-nCoV and SARS-CoV(Zhou et al., 2020).",0.15000000000000002
Further sequence alignment revealed that the similarity of the sequence of the main protease between 2019-nCoV and SARS-CoV is up to 96.1%.,0.15000000000000002
Both 2019-nCoV-S and SARS-S were comparably expressed ( Fig.,0.15000000000000002
"Thereforedespite the Spearman’s rank correlation coefﬁcient providing results for k = 1 to k = 7, the higherk-mer lengths provided more accurate results, and k = 7 was used.Attributes of the 2019-nCoV genomic signature are consistent with previously reportedmechanisms of innate immunity operating in bats as a host reservoir for coronaviruses.",0.15000000000000002
"Since  December  2019,  the  seventh  novel  human betacoronavirus (2019-nCoV) causing pneumonia outbreak was reported by the World Health  Organization.",0.15000000000000002
Identification of mouse hepatitis virus papain-like 441 proteinase 2 activity.,0.15000000000000002
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.,0.15000000000000002
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.,0.15000000000000002
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor.,0.15000000000000002
Currently there is urgent need to identify the hosts potentially infected by the 2019-nCoV viruses.,0.15000000000000002
"ACE2-Ig potently inhibited the SARS CoV-S  protein-mediated  fusion  with  an  IC50  of  0.85 g/ml,  and  the  2019  nCoV-S protein-mediated  fusion  with  an  IC50  of  0.65 g/ml.",0.15000000000000002
"The 14 contact points in the co-structure of the SARS-RBD bound to human ACE2 are largely absent from clade 2 and 3 RBDs, which also contain deletions compared to clade 1 RBMs ( figure 4a, b , s4a).",0.15000000000000002
"The same can be expected for 2019-nCoV, although affinity of SARS-S and 2019-nCoV-S for ACE2 remains to be compared.",0.15000000000000002
"To this end, large-scale local protein-protein docking was first carried out to sample a large number of thermodynamically probable conformations for the S-RBD binding to ACE2.",0.15000000000000002
Comparison of the interaction between complex of ACE2 [ 13 ] and SARS-CoV RBD and homology model of ACE2 and 2019-nCoV RBD revealed similar binding modes (data not shown).,0.15000000000000002
"2B), we obtained the starting configuration of S-RBD complexed with ACE2 for the 2019-nCoV docking (Fig.",0.15000000000000002
These data indicate that the RBD in S protein of 2019-nCoV may bind to ACE2 with the similar affinity as SARS-CoV RBD does.,0.15000000000000002
"This supports that the 2019-nCoV S-protein encoded by its genome has processed human receptor-binding ability close to that of SARS-CoV, and thus this newly emerged virus is likely able to bind to ACE2 and then to drive human-to-human transmission.",0.15000000000000002
"No doubt, such a structural distribution of the residues could lead to a different binding affinity from that of SARS-CoV S-RBD binding to ACE2.",0.15000000000000002
"Here, we perform large-scale protein-protein docking to quantify the interactions of 2019-nCoV S-protein receptor-binding domain (S-RBD) with human receptor ACE2, based on experimental SARS-CoV S-RBD-ACE2 complex structure.",0.15000000000000002
(B) The lowest-energy model of S-RBD binding to ACE2 with an energy score of -28.4 kcal·mol-1.,0.15000000000000002
"The streptavidin biosensors labelled with biotinylated 2019-nCoV RBD were saturated with human ACE2 in solution, followed by the addition of the test antibodies in the presence of ACE2.",0.15000000000000002
"Next,  the  binding  free  energy  of  S-RBD  to  ACE2  was  calculated  according  to  the thermodynamic average over the sampled, low-energy binding conformations.",0.15000000000000002
"(2020)  also  used  structural  modeling approach  to  predict  the  binding  affinity  of  S-RBD  to  ACE2  In  their  study,  two  single  complex conformations (i.e., one crystal structure and one predicted structure) were employed to calculate the binding free-energies of two CoVs, and showed that the affinity of 2019-nCoV S-RBD to ACE2 was in the order of ~65% of that for SARS-CoV.",0.15000000000000002
It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.obtained in the Monte Carlo docking simulations can be considered to be thermodynamically probable in the binding process of S-protein to ACE2.,0.15000000000000002
"Considering that the protein-protein docking has already sampled a large number of thermodynamically probable, low-energy  binding  conformations,  these  results  indicate  that  the  existence  of  an  ACE2-binding conformation for 2019-nCoV S-RBD with an energy value < -37.4 kcal·mol-1 is very limited.",0.15000000000000002
"These results suggest that CR3022, distinct from the other two SARS-CoV antibodies, recognizes an epitope that does not overlap with the ACE2 binding site of 2019-nCoV RBD.",0.15000000000000002
"So, the binding strength of 2019-nCoV S-RBD to ACE2 is unlikely greater than that of SARS-CoV S-RBD.",0.15000000000000002
"To further elucidate the binding epitopes of CR3022, we measured the competition of CR3022 and human ACE2 for the binding to 2019-nCoV RBD (Supplementary Methods).",0.15000000000000002
"The Rosetta energy function 2015 (REF15) was employed in the docking to evaluate the interaction energy of two docking components (i.e., S-RBD and ACE2).",0.15000000000000002
"The top-scoring, lowest-energy conformations were identified as the native-like conformations of the S-RBD binding to ACE2.",0.15000000000000002
"The calculated affinity (K D ) of 2019-nCoV RBD with human ACE2 was 15.2 nM ( Figure 1f ), which is comparable to that of SARS-CoV spike protein with human ACE2 (15 nM) [ 14 ].",0.15000000000000002
"As shown in  Figure 1g , the antibody CR3022 did not show any competition with ACE2 for the binding to 2019-nCoV RBD.",0.15000000000000002
"With equation 1 and all the sampled binding conformations for SARS-CoV and 2019-nCoV, the binding free-energy of SARS-CoV S-RBD to ACE2 is:   〈∆𝐺 4564〉 ≈  -36.6 kcal·mol-1                                                (2)   and that of 2019-nCoV S-RBD to ACE2 is: 	〈∆𝐺789:〉 ≈	-27.2 kcal·mol-1                                                  (3)   By comparing these two values, we found that 2019-nCoV S-RBD reaches about 73% of the binding strength of SARS-CoV S-RBD to ACE2.",0.15000000000000002
"To validate the docking approach, we first carried out local protein-protein docking to investigate the binding interactions of SARS-CoV S-RBD with ACE2, in order to test whether this approach could identify the lowest-energy conformations of S-RBD complexed with ACE2 identical or close to the experimental structure(Li et al., 2005).",0.15000000000000002
"Here, we employ protein-protein docking approach to quantify the interactions of 2019-nCoV S-RBD with ACE2, based on the experimentally determined structure of SARS-CoV S-RBD complexed with ACE2(Li et al., 2005) and on the predicted structure of 2019-nCoV S-RBD according to gene sequence.",0.15000000000000002
"High-resolution prediction of 2019-nCoV S-RBD structure   Because  the  2019-nCoVgenome  has  just  been  sequenced  for  a  very  short  period  of  time,  an experimental 3D structure for performing protein-protein docking of 2019-nCoV S-RBD to ACE2 is not  yet  available.",0.15000000000000002
"Here, we perform large-scale protein-protein docking to quantify the interactions of  2019-nCoV  S-protein  receptor-binding  domain  (S-RBD)  with  human  receptor ACE2,  based  on experimental  SARS-CoV  S-RBD-ACE2  complex  structure.",0.15000000000000002
"We also predicted the conformations of 2019-nCoV RBD and its complex with the putative receptor, human ACE2 (Supplementary Methods).",0.15000000000000002
Important residues in human ACE2 that interact with SARS-CoV spike RBD are marked.,0.15000000000000002
"(f) Binding profiles of 2019-nCoV RBD to ACE2 and antibodies, and (g) competition of CR3022 and ACE2 with 2019-nCoV RBD measured by BLI in OctetRED96.",0.15000000000000002
"The top-1 scoring model was used as the 3D structure of the 2019-nCoV  S-RBD  for  the  protein-protein  docking  with  the  experimental  structure  of  ACE2  from  PDB 6     bioRxiv preprint first posted online Feb. 3, 2020; The copyright holder forthis preprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in http://dx.doi.org/10.1101/2020.02.01.930537doi: .",0.15000000000000002
"As  we  will  show,  we  could  use  the thermodynamic average of the binding energy scores of these conformations as an experiment-based energy reference to characterize the interactions of the 2019-nCoV S-RBD binding to ACE2, and then to evaluate the relative strength with respect to that of SARS-CoV.",0.15000000000000002
Binding interactions of 2019-nCoV S-RBD with human ACE2   With the complex model in Fig.,0.15000000000000002
The previously determined 12  crystal structure of SARS-CoV RBD complexed with human ACE2 (PDB 2AJF) revealed that regions 473-477 and 460-472 directly interact with human ACE2 and hence may be important in determining species specificity ( Figure 4b ).,0.15000000000000002
Figure 3 | Binding interactions between 2019-nCoV S-RBD and the human receptor ACE2.,0.15000000000000002
This demonstrates that the docking has identified the native-like interacting conformations for the 2019-nCoV  S-RBD  binding  to  ACE2.,0.15000000000000002
"Using this approach, we sampled a large number of low-energy conformations of S-RBD in complex with ACE2 by preforming multiple, independent docking runs (i.e., simulations), and calculated their   binding energies with a physically realistic, all-atom energy function for macromolecular modeling and design(Alford et al., 2017).",0.15000000000000002
"It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.are considered to be accessible in the real-world process of S-protein binding to ACE2, depending on their thermodynamic probabilities determined by the binding energies.",0.15000000000000002
The epitope of CR3022 does not overlap with the ACE2 binding site within 2019-nCoV RBD.,0.15000000000000002
"(2011), the co-crystal structure of SARS-CoV S-RBD in complex with ACE2 (PDB 2AJF) was used as  the  starting  complex  for  the  local  protein-protein  docking.",0.15000000000000002
"Results and Discussion     Binding interactions of SARS-CoV S-RBD with human ACE2   To quantify the binding interactions of CoV S-protein with ACE2, we employed the well-established method of local protein-protein docking implemented in Rosetta software suite(Das and Baker, 2008).",0.15000000000000002
"Indeed, we measured the binding of 2019-nCoV RBD to human ACE2 by the biolayer interferometry binding (BLI) assay, and found that 2019-nCoV RBD bound potently to ACE2.",0.15000000000000002
"The successful identification of the experimental complex structure as the lowest-energy binding conformations also validates the accuracy of the used Rosetta all-atom energy function(Alford et al., 2017)  for  quantifying  the  interactions  of  S-RBD  with ACE2.",0.15000000000000002
Figure 1 | Binding interactions between SARS-CoV S-RDB and the human receptor ACE2.,0.15000000000000002
"It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.Conclusions We have performed large-scale protein-protein docking to evaluate the binding affinities of SARS-CoV and 2019-nCoV S-RBDs to the human receptor ACE2, in order to quantitatively assess the human receptor-binding capability of 2019-nCoV.",0.15000000000000002
"Severe acute respiratory syndrome (SARS)-CoV in 2002-2003 and the Middle East respiratory syndrome (MERS)-CoV in 2012-2015 both belong to the genus  Betacoronavirus  [ 4 , 5 ].",0.15000000000000002
"In contrast, five bat SARS-like CoVs had amino acid deletions at two motifs (amino acids 473-477 and 460-472) compared with those of SARS-CoV, and Rp3 has been reported not to use ACE2.",0.15000000000000002
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.,0.15000000000000002
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.,0.15000000000000002
"We then infected BHK cells expressing the receptor for SARS-CoV or empty vector ( figure 1e ) and observed only clade 1, which includes SARS-CoV, WIV1 and SHC014, could enter cells transfected with human ACE2 ( figure 1e ).",0.15000000000000002
It was shown that angiotensin-converting enzyme 2 (ACE2) was the cellular receptor of the SARS virus S protein ( 4 ).,0.15000000000000002
"Known host receptors for β-CoVs include angiotensin converting enzyme 2 (ACE2) for SARS-CoV and dipeptidyl peptidase 4 (DPP4) for MERS-CoV 13 ,  14 .",0.15000000000000002
"The RBD sequences of WHCV were more closely related to those of SARS-CoVs (73.8%-74.9% aa identity) and SARS-like CoVs including strains Rs4874, Rs7327 and Rs4231 (75.9%-76.9% aa identity) that are able to use the human ACE2 receptor for cell entry (Table S7) 10 .",0.15000000000000002
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.,0.15000000000000002
"Importantly, we have confirmed that 39 this novel CoV uses the same cell entry receptor, ACE2, as SARS-CoV.",0.15000000000000002
"Importantly, we have confirmed that this novel CoV uses the same cell entry receptor, ACE2, as SARS-CoV.",0.15000000000000002
"[11] Hamming I, Timens W, Bulthuis MLC, Lely AT, Navis GJ, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus.",0.15000000000000002
138  139 Angiotensin converting enzyme II (ACE2) was known as cell receptor for SARS-140 CoV14.,0.15000000000000002
SARS-S engages angiotensin-converting enzyme 2 (ACE2) as entry receptor ( 14 ) and employs the cellular serine protease TMPRSS2 for S protein priming ( 15 - 17 ).,0.15000000000000002
"Moreover, it is noteworthy that ACE2 expression is not limited to the lung and that extrapulmonary spread of SARS-CoV in ACE2 +  tissues was observed ( 29 ,  30 ).",0.15000000000000002
Angiotensin-Converting Enzyme 2 Is a Functional Receptor for the Sars Coronavirus.,0.15000000000000002
"Using the well-investigated SARS-CoV as the reference, our  results  showed  that  2019-nCoV  reaches  about  73%  of  the ACE2  receptor-binding  strength  of SARS-CoV.",0.15000000000000002
"In this branching process, the effective reproduction number (accounting for control interventions, other than intensified surveillance which we model explicitly) of the 2019-nCoV when the virus arrives in a new location is denoted by  R  =  β/γ , where the parameter  β  represents pathogen transmissibility [ 16 ].",0.15000000000000002
"Additionally, the Cl atom of the ternary ring and the methanethiol inresidue Cys144.Essentially, the hydrogen bond acceptor such as Cl and O atoms in the drug candidate molecules are criticalto the binding to 2019-nCoV protease.",0.15000000000000002
"Structural proteins  Spike  (S),  and  Membrane  (M)  had  extensive  mutational  changes,  whereas Envelope  (E)  and  Nucleocapsid  (N)  proteins  were  very  conserved  suggesting differential  selection  pressures  exerted  on  2019-nCoV  during  evolution.",0.15000000000000002
"Our docking results showed that three of the hydrogen bonds involving GLU-166 and GLN-189 maintained upon the binding of nelfinavir and 2019-nCov M pro , with additionally the possible formation of π-π stacking interaction with HIS-41 ( Figure 2d ).",0.15000000000000002
"Thus, the main protease is highly conserved and main protease 5n5ocan be used as a homologous target for screening of possible drugs against 2019-nCoV.",0.15000000000000002
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines.,0.15000000000000002
The hydrogens were added to 2019-nCov M pro  model by pdb2pqr (--ff=amber --ffout=amber --chain --with-ph=7).,0.15000000000000002
The authors thank Zihe Rao & Haitao Yang group at ShanghaiTechnological University for providing the crystal structure of 2019-nCoV 3CL hydrolase (PDB ID 6lu7) and thankDr.,0.15000000000000002
"The conserved amino acids Thr24-Asn28 and Asn119 (numbered according to positions in SARS-CoV M pro  as the present sequence of 2019-nCoV M pro  in GenBank is in polypeptide form) formed the binding pockets for lopinavir/ritonavir in the spatial structure of both SARS-CoV M pro  and 2019-nCoV M pro , whereas the nearby non-conserved amino acids locate far away from the binding pocket, thus would not affect its structural conservation ( Figure 1b ).",0.15000000000000002
"Amino acid sequences of 3C-like proteinase (accession YP_009725301.1), RNA-dependent RNA polymerase (accession YP_009725307.1), helicase (accession YP_009725308.1), 3’-to-5’ exonuclease (accession YP_009725309.1), endoRNAse (accession YP_009725310.1), and 2’-O-ribose methyltransferase (accession YP_009725311.1) of the 2019-nCoV replication complex were extracted from the 2019-nCoV whole genome sequence ( accession  NC_045512.2 ), from the National Center for Biotechnology Information (NCBI) database.",0.15000000000000002
2019-nCov M pro  is a potential drug target to combat the virus.,0.15000000000000002
Studies for identifying the inhibitors of 2019-nCov M pro  were quickly performed for discovering and developing drugs against the disease.,0.15000000000000002
"All isolates of 2019-nCoV however, have the same CDS of M and E.",0.15000000000000002
"Maximum likelihood phylogenetic trees of the nucleotide sequences of the 3CL, RdRp, Hel, ExoN, NendoU, and O-MT genes of WHCV and related coronaviruses.",0.15000000000000002
The protein sequences of SARS-CoV M pro  (Accession: 1UK3_A) and 2019-nCoV polyprotein orf1ab (Accession: YP_009724389.1) were downloaded from GenBank ( http://www.ncbi.nlm.nih.gov ).,0.15000000000000002
"(a) Binding models of the original ligand (TG-0205221, white) in 2GX4 and nelfinavir (cyan) in the 2019-nCov M pro  protein pocket (white surface); (b) Superposition of TG-0205221 (white) and nelfinavir (cyan) in their binding conformations; (c) Interactions between TG-0205221 and associated residues in the crystal structure (2GX4) of SARS M pro ; (d) Interactions between nelfinavir and associated residues in the homology model of 2019-nCov M pro .",0.15000000000000002
"Structure of 2019-nCoV M pro  was predicted by Modeller algorithm (Webb and Sali, 2016) using the structure of SARS-CoV M pro  as template.",0.15000000000000002
"Ribbon model shows the pocket structure of 2019-nCoV M pro  (right), with α-helixes shown in red and β-sheets in cyan.",0.15000000000000002
Virtual screening of medicines with binding potential to the pocket site of 2019-nCoV M pro  was performed using the Libdock algorithm of Discovery Studio 3.5 (Accelrys Software Inc).,0.15000000000000002
"In this study, we have identified 4 small molecular drugs with high binding capacity with SARS-CoV main protease by high-throughput screening based on the 8,000 clinical drug libraries, all these drugs have been widely used in clinical applications with guaranteed safety, which may serve as promising candidates to treat the infection of 2019-nCoV.",0.15000000000000002
"It is made available under a CC-BY-NC 4.0 International license.perpetuity.NC_045512.2) and then translated into amino acid residues according to the coding sequence positions provided  along  the  reference  sequence  for  the  2019-nCoV  proteins  (orf1a,  orf1b,  S,  ORF3a,  E,  M, ORF6,  ORF7a,  ORF8,  N,  and  ORF10).",0.15000000000000002
"With the hope to identify candidate drugs for 2019-nCoV, we adopted a computational approach to screen for available commercial medicines which may function as inhibitors for the M pro  of 2019-nCoV.",0.15000000000000002
"For validation, we modelled 10 additional new models of 2019-nCov M pro  and docked the 15 drugs against the new models, which revealed that 6 drugs (nelfinavir, praziquantel, pitavastatin, perampanel, eszopiclone, and zopiclone) have good binding modes with the new models.",0.15000000000000002
"In summary, basing on the structural information of clinical effective medicines for 2019-nCoV, we have predicted a list of commercial medicines which may function as inhibitors for 2019-nCoV by targeting its main protease M pro .",0.15000000000000002
"Taking into account its high 3D similarity of binding mode to the known M pro  inhibitor, we proposed that nelfinavir should be a potential inhibitor against 2019-nCov M pro .",0.15000000000000002
"Ribbon models show the pocket structure of SARS-CoV M pro  (left) and 2019-nCoV M pro  (right), with α-helixes shown in red and β-sheets in cyan.",0.15000000000000002
"The pocket site of 2019-nCoV M pro  was identified by homology comparison to a previous published work ( Nukoolkarn et al., 2008 ).",0.15000000000000002
Docking model of candidate inhibitors drugs to 2019-nCoV Mpro.,0.15000000000000002
Sequence alignment revealed that the M pro  of 2019-nCov shares 96% similarity with that of SARS (severe acute respiratory syndrome) ( Figure 1 ).,0.15000000000000002
"2019-nCov M pro  is a potential drug target to combat the virus, which shares 96% sequence similarity with the corresponding one in SARS.",0.15000000000000002
"Drug-target interaction (DTI) prediction results of FDA approved antviral drugs available on markets against a novel coronavirus (2019-nCoV, NCBI reference sequence NC_045512.2) 3C-like proteinase (accession YP_009725301.1).",0.15000000000000002
The  high  affinity  epitopes  identified  in  the  functionally  important  regions  of  Spike  and Membrane  proteins  could  be  critical  in  modulating  immune  responses  to  circulating 2019-nCoV.,0.15000000000000002
"Structural proteins Spike (S), and Membrane (M) had extensive mutational changes, whereas Envelope (E) and Nucleocapsid (N) proteins were very conserved suggesting differential selection pressures exerted on 2019-nCoV during evolution.",0.15000000000000002
"Basing on these results, we performed virtual docking to screen for commercial medicines in the DrugBank database that could bind to the above mentioned pocket site of 2019-nCoV M pro , and identified 10 candidate clinical medicines ( Table 1 ,  Figure 1d  and  Supplementary Figure 2 ).",0.15000000000000002
Sequence alignment of 2019-nCov M pro  and SARS M pro .,0.15000000000000002
"Maximum likelihood phylogenetic trees of nucleotide sequences of the ORF1a, ORF1b, E and M genes of WHCV and related coronaviruses.",0.15000000000000002
Screen for potential 2019-nCoV M pro  inhibitors from commercial medicines.,0.15000000000000002
Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approvedmedicines.,0.15000000000000002
"Although HIV drugs Kaletra(or Aluvia) and Norvir might indeed have a moderate effect in the treatment of 2019-nCoV, the analysis ofthese anti-HIV/AIDS drugs together with our top 15 anti-2019-nCoV molecules shows that the new compoundsgenerated by our GNC appear to have better druggable properties than these HIV inhibitors do.Supplementary materialsSupplementaryMaterial-1.csv: A list of SMILES strings, predicted binding afﬁnities, logP, logS and synthesizabil-ity of 319 potential inhibitors of 2019-nCoV 3CL protease, including two anti-HIV protease drugs.SupplementaryMaterial-2.csv: The SMILES strings, experimental binding afﬁnities of 115 potential SARSinhibitors from ChEMBL.",0.15000000000000002
"Based on its function, the main protease (M pro ) or chymotrypsin-like protease (3CL pro ) 4  is suggested to be a potential drug target to combat 2019-nCov, which is highly conservable among coronaviruses.",0.15000000000000002
"Therefore, our 2019-nCoVtraining set is built up by 115 SARS-CoV protease inhibitors.",0.15000000000000002
"Therefore, we suggested that nelfinavir might be a potential inhibitor against 2019-nCov M pro .",0.15000000000000002
A. Sequence comparison between 2019-nCoV M pro  and SARS-Cov M pro .,0.15000000000000002
"To map the structural variability of the N, E, S and M regions of the virus and their sites under selection pressure, homology modelling has been applied on the sequence of 2019-nCoV.",0.15000000000000002
Predicted commercial medicines as potential inhibitors for 2019-nCoV M pro .,0.15000000000000002
"1903 approved drugs in pdbqt format were docked to 2019-nCov M pro  model (template: 2GTB) by smina, 11  which is a fork of AutoDock Vina 12  with improving scoring and minimization.",0.15000000000000002
"Clinical application of these two drugs on 2019-nCoV patients also appears to be effective, demonstrating the importance of the drug binding site for suppressing 2019-nCoV M pro  activity.",0.15000000000000002
"The binding pockets of these drugs on M pro  are conserved between SARS-CoV M pro  and 2019-nCoV M pro , indicating the potential of these drugs to function as inhibitors for other coronaviruses with similar M pro  binding sites and pocket structures.",0.15000000000000002
"The protein sequence of 2019-nCoV M pro  was determined by aligning the SARS-CoV M pro  sequence to 2019-nCoV polyprotein orf1ab using BLAST ( Altschul et al., 1990 ), the best aligned region in 2019-nCoV orf1ab to SARS-CoV M pro  was selected as 2019-nCoV M pro .",0.15000000000000002
"The predicted S, ORF3a, E, M and N genes of WHCV are 3,822, 828, 228, 669 and 1,260 nt in length, respectively.",0.15000000000000002
"To determine the evolutionary relationships between WHCV and previously identified coronaviruses, we estimated phylogenetic trees based on the nucleotide sequences of the whole genome sequence, non-structural protein genes ORF1a and 1b, and the main structural proteins encoded by the S, E, M and N genes ( Figures 3  and S4).",0.15000000000000002
We built 11 homology models of 2019-nCov M pro  and docked 1903 approved small molecule drugs to the 2GTB model.,0.15000000000000002
These observations further demonstrated that nelfinavir would interact with key residues of 2019-nCov M pro  in a similar way to that of the existing inhibitors against coronavirus M pro .,0.15000000000000002
"These drugs could form hydrogen bonds with one or more residues among Thr24-Asn28 and Asn119, theoretically, are capable to bind to the pocket formed by these amino acids and interfere the function of 2019-nCoV M pro .",0.15000000000000002
"For finding more potential drugs as inhibitors of the protein, we modelled the 2019-nCov M pro  structures using SARS M pro  (PDB ID: 2GTB) as template and docked 1903 approved drugs against the model in this study.",0.15000000000000002
"The new 2019-nCoV was annotated slightly different from the human SARS virus and other coronaviruses, but the functionally important ORFs, ORF1a and ORF1b, and major structural proteins including the spike (S), membrane (M) and envelop (E) and nucleic capsid (N) proteins are well annotated ( Fig 1b ).",0.15000000000000002
"To search for other drugs that may inhibit 2019-nCoV M pro , we first evaluated the sequence and structural conservation of lopinavir/ritonavir bind site between SARS-CoV and 2019-nCoV.",0.15000000000000002
"7  11 complexes (PDB IDs: 2A5K, 2GTB, 2GX4, 3SND, 3TNS, 3V3M, 4F49, 4YLU, 5NH0, 5WKJ, 5WKM) were served as templates to build 11 2019-nCov M pro  models in SWISS-MODEL server by “user template” mode.",0.15000000000000002
"Therefore, we suggested that nelfinavir might be active against 2019-nCov M pro .",0.15000000000000002
Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening.,0.15000000000000002
"A previous attempt to predict drugs for the M pro  of SARS-CoV has identified two HIV-1 protease inhibitors, namely lopinavir and ritonavir, as potential candidates, both of which bind to the same target site of M pro  ( Nukoolkarn et al., 2008 ).",0.15000000000000002
Docking model of ritonavir to 2019-nCoV M pro .,0.15000000000000002
"Nukoolkarn, V., Lee, V. S., Malaisree, M., Aruksakulwong, O. and Hannongbua, S. Molecular dynamicsimulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors.",0.15000000000000002
"Left, overall docking model of ritonavir to 2019-nCoV M pro ; middle, enlargement of the ritonavir binding region; right, predicted chemical bonds between ritonavir and key residues of the binding pocket.",0.15000000000000002
"Notably, WHCV is most closely related to bat coronaviruses, even exhibiting 100% aa similarity to Bat-SL-CoVZC45 in the nsp7 and E proteins.",0.15000000000000002
"For example, the analysis of the first released 2019-nCoV sequence, the WH_Human1_China_2019Dec (GenBank:  MN908947 ) demonstrated at genome level, the nucleotide (NT) identity was 79.0% to the reference strain of SARSr-CoV (ACCESSION:  NC_004718.3 ) and that the Envelop Small Membrane Protein (protein E) is the most similar protein.",0.15000000000000002
"Detailed sequence alignment showed that 2019-nCoV exhibited significant sequence variation at several regions with the human SARS coronavirus including the N-terminal region of ORF1a and S protein, ORF3, E, ORF6, 7 and 8, and the middle part of N protein.",0.15000000000000002
"2019-nCoV genome (30 Kb in size) codes for a large non-structural polyprotein ORF1ab that is proteolytically cleaved to generate 15/16 proteins, and four structural proteins - Spike (S),  Envelope  (E),  Membrane  (M)  and  Nucleocapsid  (N),  as  well  as  five  accessory proteins  (ORF3a,  ORF6,  ORF7a,  ORF8  and  ORF10).",0.15000000000000002
"At present, six full genomes of 2019-nCoV have been submitted on GISAID  ( 3 )  by China CDC,  etc ., and among them one has been released on GenBank  ( 4 )  (Accession:  MN908947 ).",0.15000000000000002
"The Centre for Disease Control and Prevention, the United States, also emphasised the importance of wearing a facemask at all times when staying with infected individuals in shared spaces as one of precautions for large-scale spreads in community, specified in their interim guidance for prevention for 2019-nCoV from spreading in home and communities[17].",0.15000000000000002
Further analysis 77 indicates that some of the nCoV-2019 genes shared less than 80% nt sequence 78 identity to SARS-CoV.,0.15000000000000002
"(A) MSA of the coronavirus proteins encoded by ORF8 in representative sequences for the 2019-nCoV (Wuhan), BCoVs (batSARSLike and batSARS) and SARS viruses.",0.15000000000000002
"The closest 3D model to 2019-nCoV ORF8 available in Protein Data Bank [14] is a short 22 aminoacid  stretch  in  the  protein  entry  6P65,  with  a  non-significant  E-value  of  0.848.",0.15000000000000002
"Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hyper-variable genomic hotspots, one of which is responsible for a Serine/Leucine variation in the viral ORF8-encoded protein.",0.15000000000000002
"Despite the low heterogeneity of the 2019-nCoV genomes, we could identify at least two hyper-variable genomic hotspots, one  of  which is responsible for a  Serine/Leucine variation in the viral ORF8-encoded protein.",0.15000000000000002
"d, Phylogenetic tree based on 240 nucleotide sequences of complete ORF1b of coronaviruses.",0.15000000000000002
A novel coronavirus was then isolated from the human airway epithelial cells and was named 2019 novel coronavirus (2019-nCoV)[ 2 ].,0.15000000000000002
"The N region of the 2019-nCoV homology model has been built using a SARS coronavirus nucleocapsid protein structure (2jw8.1) since the statistical test have shown that this is the most stable and similar model among the other possible structures (Ramachandran Favoured 90.52%, GMQE 0.17, QMEAN -2.43), while for the S region the 2019-nCoV homology model has been built using a SARS coronavirus spike glycoprotein (6acc.1) for the same reasons (Ramachandran Favoured 87.87%, GMQE 0.83, QMEAN -3.14)",0.15000000000000002
"Interestingly, 2019-nCoV Spike protein contains a 39 nucleotide sequence insertion relative to SARS-like bat-SL-CoVZC45/2017.",0.15000000000000002
"Homology of S protein of 2019-nCoV with representative human SARS virus, bat SARS like viruses and bat coronaviruses was determined as shown in Table S2.",0.15000000000000002
"Spike (S) proteins of coronaviruses, including the coronavirus that  causes  severe  acute  respiratory  syndrome  (SARS)  and  the  2019-nCoV, associate  with  cellular receptors to  mediate infection  of their target  cells.",0.15000000000000002
"The sequences of the spike RBD domains of WHCV, Rs4874 and Rp3 were searched by BLAST against the primary amino acid sequence contained in the SWISS-MODEL template library (SMTL, last update: 2020-01-09, last included PDB release: 2020-01-03).",0.15000000000000002
Our  alignment  result  suggests  a  possible  occurrence  of  recombination  and  non-synonymous  changes  in  Spike  gene  of  2019-nCoV  which  can  alter  the  preference  of viral attachment to host receptor.,0.15000000000000002
"The structural analysis of two important viral protein, the nucleocapsid and the spike-like nucleoprotein (protein S), confirmed the significant similarity the new coronavirus with the bat-like SARS coronavirus and its difference from SARS coronavirus.",0.15000000000000002
"2), we found that none of these mapped  identically  to  the  2019-nCoV  S  protein,  in  contrast  to  the  linear  epitopes.",0.15000000000000002
"From phylogenetic analysisof the RdRp protein, spike proteins, and full genomes of 2019-nCoV and other coronaviruses, it wasfound that 2019-nCoV is most closely related to two bat SARS-like coronaviruses, bat-SL-CoVZXC21and bat-SL-CoVZC45, found in Chinese horseshoe bats Rhinolophus sinicus [12,34–38].",0.15000000000000002
"The  genome  alignment  between  the  novel  and  bat  (bat/Yunnan/RaTG13/2013) coronaviruses  showed  2  of  7  insertions  (Table  1A)  in  Spike  gene,  whereas  the alignment  of  2019-nCoV  with  distantly  related  SARS-like  bat-SL-CoVZC45/2017 showed  9  of  15  insertions  and  2  of  5  deletions  (Figure  1C;  Table  1B)  in  Spike  gene.",0.15000000000000002
"Therefore, it is urgent to experimentally determine the cross-reactivity of anti-SARS-CoV antibodies with 2019-nCoV spike protein, which could have important implications for rapid development of vaccines and therapeutic antibodies against 2019-nCoV.",0.15000000000000002
"S1 makes up the large receptor-binding domain (RBD) to facilitates virus infection by binding to host receptors and S2 forms the stalk of thespike molecule.11 Therefore, one possible way to control the infection is to seek protease inhibitors to preventthe S-protein of 2019-nCoV cleaved into S1.",0.15000000000000002
"Considering the relatively high identity of receptor binding domain (RBD) in 2019-nCoV and SARS-CoV, it is urgent to assess the cross-reactivity of anti-SARS-CoV antibodies with 2019-nCoV spike protein, which could have important implications for rapid development of vaccines and therapeutic antibodies against 2019-nCoV.",0.15000000000000002
Coronaviruses use their spike proteins to select and enter target cells and insights into nCoV-2019 spike (S)-driven entry might facilitate assessment of pandemic potential and reveal therapeutic targets.,0.15000000000000002
"Using modeled S protein structure and by further performing structure-based alignment, we obtained the complex structure of RBD of the S protein of 2019-nCoV and several bat coronaviruses with human ACE2, using the complex structure of RBS of S protein from human SARS virus and ACE2 (2ajf) as reference ( 5 ).",0.15000000000000002
"The amino-acid sequence of 2019-nCoV S-protein was taken from the first genome sequence of a 2019-nCoV isolate (Wuhan-Hu-1) deposited in GenBank on January 12, 2020 (GenBank No: MN908947.3)(Wu et al., 2020).",0.15000000000000002
"When compared with the other 2019-nCoVs, EPI_ISL_403928 has four variations in S protein (T572I, G799V, F800C and N801K) and two variations in N protein (A414C and D415I).",0.15000000000000002
"Interestingly, some of the most potent SARS-CoV-specific neutralizing antibodies (e.g., m396, CR3014) that target the ACE2 binding site of SARS-CoV failed to bind 2019-nCoV spike protein, indicating that the difference in the RBD of SARS-CoV and 2019-nCoV has a critical impact for the cross-reactivity of neutralizing antibodies, and that it is still necessary to develop novel monoclonal antibodies that could bind specifically to 2019-nCoV RBD.",0.15000000000000002
This result reveals that mutations in spike protein may contribute to changes in viral virulence observed in 2019-nCoV.,0.15000000000000002
"S protein of 2019-nCoV showed about 76% homology to human SARS virus P2 and high homology to bat SARS like viruses, while it showed 72% homology to closest bat coronavirus, bat coronavirus BM48-31, even lower homology with other bat coronaviruses.",0.15000000000000002
Evolution  of  the  novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission.,0.15000000000000002
"Regarding the sites under positive selective pressure found on the Spike Glycoprotein, the results have shown that the 536th aminoacidic position in 2019-nCoV has an asparagine residue while the Bat SARS-like coronavirus has a glutamine residue, the SARS virus, instead, has an aspartic acid residue.",0.15000000000000002
described homologous recombination within the spike glycoprotein of 2019nCoV favoring cross-species transmission and suggested snake as probable virus reservoir for human infection because its Resampling Similarity Codon Usage (RSCU) bias is more similar to  Bungarus multicinctus  snake compared to other animals and humans[ 3 ].,0.15000000000000002
The high level similarity observable between the structures of S protein from different viruses implied that the S protein of 2019-nCoV and bat coronaviruses would most likely use the same human cell receptor as SARS virus.,0.15000000000000002
These data prompted us to determine the level of interaction between the S protein of 2019-nCoV with its potential cellular receptor ACE2.,0.15000000000000002
"Maximum likelihood phylogenetic trees of the nucleotide sequences of the whole genome, S and N genes of WHCV and related coronaviruses.",0.15000000000000002
( A ) The S protein of 2019-nCoV clusters phylogenetically with S proteins of known bat-associated betacoronaviruses (see also SI  Figure 1  for more details).,0.15000000000000002
"331  332 For qPCR analysis, primers based on nCoV-2019 S gene was designed: RBD-qF1: 5’-333 CAATGGTTTAACAGGCACAGG-3’; RBD-qR1: 5’-334 CTCAAGTGTCTGTGGATCACG-3’.",0.15000000000000002
(a) Phylogenetic analysis of 2019-nCoV spike glycoprotein from its protein BLAST sequences.,0.15000000000000002
"Specifically, in the 5’-part spanning the first 11,498 nucleotides and the last 3’-part spanning 24,341-30,696 positions, 2019-nCoV and RaTG13 formed a single cluster with Bat-SARS-like coronavirus sequences, whereas in the middle region spanning the 3’-end of ORF1a, the ORF1b and almost half of the spike regions, 2019-nCoV and RaTG13 grouped in a separate distant lineage within the sarbecovirus branch.",0.15000000000000002
Evolutionof the novel coronavirus from the ongoing wuhan outbreak and modeling of its spike protein for risk of humantransmission.,0.15000000000000002
One previous study based on codon usage analyses suggested that the spike protein of 2019-nCoV might have originated from one yet-unknown unsampled coronavirus through recombination [ 28 ].,0.15000000000000002
"Results  An isolate numbered EPI_ISL_403928 showed different phylogenetic trees and genetic distances of the whole length genome, the coding sequences (CDS) of ployprotein (P), spike protein (S), and nucleoprotein (N) from other 2019-nCoVs.",0.15000000000000002
"In the middle region spanning the 3’-end of ORF1a, the ORF1b and almost half of the spike regions (10,901-22,830 nts in the alignment or 11,499-24,340 of the NC_045512), 2019-nCoV and RaTG13 grouped in a separate distant lineage within the sarbecovirus branch ( figure 1B, 1C ).",0.15000000000000002
"Comparison  of  Spike  protein  of  2019-nCoV  and  bat  CoV bat/Yunnan/RaTG13/2013  showed  97.7%  sequence  identity  with  29  non-synonymous changes and 4 amino acid insertions (position 681-684, PRRA) (Table 1C).",0.15000000000000002
"For  3  of  these discontinuous B cell epitopes there was a partial mapping, with at least one site having an identical residue at the corresponding site in the 2019-nCoV S protein (Table 7).",0.15000000000000002
Bat MG772934.1 Bat DQ022305.2 SARS NC_004718.3 Gene ORF1ab (polyprotein) S (Spike) Orf3a E (Envelope) M (Membrane) ORF6 ORF7a ORF7b ORF8 N (Nucleocapsid) ORF10  95.15% 80.32% 92.00% 100% 98.65% 93.44% 88.43% 93.02% 94.21% 94.27% 73.20% 85.78% 76.04% 72.99% 94.74% 90.99% 67.21% 88.52% 79.07% 57.02% 89.55% 74.23% 86.12% 75.96% 72.36% 94.74% 90.54% 68.85% 85.25% 81.40% 30.16% 90.52% 72.45% Table  1:  percentage  identity  between  the  human  reference  nCoV  proteins  and  other  coronavirus representatives.,0.15000000000000002
Analysis of receptor-binding domain (RBD) of the spike (S) protein of WHCV coronavirus.,0.15000000000000002
Synthesizing just the RBD of spike is much faster and cost-effective than conventional pseudotyping methods that rely on synthesis of the full ∼4kb spike sequence for novel CoVs: a process that can take weeks and is cost-prohibitive for large panels of spike sequences.,0.15000000000000002
The chimeric SARS-2019-nCoV spike protein expressed and was incorporated into particles similarly to other clade 1 chimeric spikes ( figure 3c ).,0.15000000000000002
All these results illustrate the efficiency of our computational prediction and the high risk of 2019-nCoV and guide us to have a closer look at the similarity and differences of 2019-nCoV and SARS-CoV-like Coronaviruses.,0.15000000000000002
"Genome based  phylogenetic  tree  analysis  revealed  a  major  cluster  of  large  clade  was  formed with  humans  2019-nCoV  strains, SARS-CoV-like strains  from  bats and  human  SARS-CoV  viruses  (Figure  1A)  with  100  bootstrap  support.",0.15000000000000002
"Although the similarity plots suggested possible recombination events between WHCV and SARS CoVs or SARS-like CoVs (Figure S7), there was no significant evidence for recombination across the genome as a whole.",0.15000000000000002
"Other groups found that twobat SARS-like coronaviruses, bat-SL-CoVZC45 and bat-SL-CoVZXC21, were also closely related to2019-nCoV [12,34–38].",0.15000000000000002
"To explore the differences of 2019-nCoVs, SARS and SARS-CoV-like Coronavirus, we then analyzed their core genes (more than 95% AAS identity) and nonsynonymous SNPs (single-nucleotide polymorphisms) (Table S3).",0.15000000000000002
"When the 2019-nCoV isolated from France (BetaCoV/France/IDF0373/2020) was analysed with our tool and compared with the 2019-nCOv WH_Human1_China_2019Dec strain (Accession:  MN908947 ), this sequence was 99.9% identical and had only two NT mutations (Supplementary Table 4C).",0.15000000000000002
"For example, severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are the most impressive ones.",0.15000000000000002
Our estimates of  R 0  and  k  are more similar to previous estimates focusing on early human-to-human transmission of SARS-CoV in Beijing and Singapore[ 4 ] than of MERS-CoV[ 6 ] ( figure 3 ).,0.15000000000000002
"Mutation is defined here as an amino acid difference from the reference sequence of the respective  coronavirus;  accession (SARS-CoV),  and NC_019843.3 (MERS-CoV).",0.15000000000000002
"Second, the risk of superspreading events could be similar to SARS-CoV and MERS-CoV, but is unlikely to be higher.",0.15000000000000002
"Previous studies have found that six strains of coronaviruses are capable to infect human, including four strains circulating yearly to cause common cold, and other two strains which the source for severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS-CoV), respectively ( Cui et al., 2019 ;  Dhama et al., 2014 ).",0.15000000000000002
"On 31 December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China, and WHO reported that a novel coronavirus (2019-nCoV) was identified as the causative virus by Chinese authorities on 7 January( 1 ).",0.15000000000000002
"The recent outbreak of pneumonia in Wuhan, China caused by the 2019 Novel Coronavirus (2019-nCoV) emphasizes the importance of detecting novel viruses and predicting their risks of infecting people.",0.15000000000000002
"Nucleotide-resolution maps of the learned associations between pathogen genomes and the infectious phenotype can be used to detect virulence-related genes in novel agents, as we show here for the 2019-nCoV coronavirus, unknown before it caused a pneumonia outbreak in December 2019.",0.15000000000000002
"In December 2019, a novel identified coronavirus (2019-nCov) induced an ongoing outbreak of pneumonia in Wuhan, Hubei, China with arising number of infected patients[ 4 ].",0.15000000000000002
A  pneumonia  outbreak  associated  with  a  new  coronavirus  of  probable  bat  origin.,0.15000000000000002
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humansand its potential bat origin.,0.15000000000000002
"The recently outbreak of pneumonia in Wuhan, China has brought the 2019 Novel Coronavirus (2019-nCoV) into our sight closely.",0.15000000000000002
A pneumonia outbreak associated with a new coronavirus of probable bat origin.,0.15000000000000002
"In this study, we utilized the whole genome sequence of the newly discovered coronavirus, 2019-nCoV, that caused an outbreak of pneumonia in Wuhan, China to perform comparative genetic and functional analysis with the human SARS virus and coronaviruses recovered from different animals.",0.15000000000000002
"Finally, we analyzed the 2019-nCoV coronavirus, which emerged in December 2019, causing a pneumonia outbreak ( Wu et al., 2020 ).",0.15000000000000002
"1 2 3 4 5 6 7 8 9 Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin  Peng Zhou1*, Xing-Lou Yang1*, Xian-Guang Wang2*, Ben Hu1, Lei Zhang1, Wei Zhang1, Hao-Rui Si1,3, Yan Zhu1, Bei Li1, Chao-Lin Huang2, Hui-Dong Chen2, Jing Chen1,3, Yun Luo1,3, Hua Guo1,3, Ren-Di Jiang1,3, Mei-Qin Liu1,3, Ying Chen1,3, Xu-Rui Shen1,3, Xi Wang1,3, Xiao-Shuang Zheng1,3, Kai Zhao1,3, Quan-Jiao Chen1, Fei Deng1, Lin-Lin Liu4, Bing Yan1, Fa-Xian Zhan4, Yan-Yi Wang1, Geng-Fu Xiao1, 10 Zheng-Li Shi1† 11  12 Affiliations:  13 1CAS Key Laboratory of Special Pathogens, Wuhan Institute of Virology, Center for 14 Biosafety Mega-Science, Chinese Academy of Sciences, Wuhan, People’s Republic 15 of China 16 2Wuhan Jinyintan hospital, Wuhan, China 17 18 3University of Chinese Academy of Sciences, Beijing, People’s Republic of China 4Hubei Provincial Center for Disease Control and Prevention, Wuhan, People’s 19 Republic of China 20 *These authors contributed equally.",0.15000000000000002
"Genomic and protein structure modelling analysis depicts the origin and infectivity of2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China.",0.15000000000000002
A pneumonia outbreak associated with a new coronavirus of probable bat origin.,0.15000000000000002
"The infectious agent driving the ongoing pneumonia outbreak (the 2019-nCoV) appears to have transitioned from animals into humans at Huanan seafood wholesale market in Wuhan, China [ 1 – 5 ].",0.15000000000000002
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin.,0.15000000000000002
"2019 Novel Coronavirus (2019-nCoV) is a virus identified as the cause of the outbreak of pneumonia first detected in Wuhan, China.",0.15000000000000002
"At the time of writing, 14,441 cases of  2019-nCoV-related  pneumonia  cases  have  been  reported  in  China,  plus  118  cases  from  23  other countries.",0.15000000000000002
"Since December 2019, a newly identified coronavirus (2019 novel coronavirus, 2019-nCov) is causing outbreak of pneumonia in one of largest cities, Wuhan, in Hubei province of China and has draw significant public health attention.",0.15000000000000002
"Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-ncov, anew coronavirus which caused a pneumonia outbreak in wuhan, china.",0.15000000000000002
"Meanwhile, the outbreak of pneumonia caused by 2019-nCoV warns us the importance of predicting the risk of novel virus infection of human.",0.15000000000000002
"Backgrounds  An ongoing outbreak of a novel coronavirus (2019-nCoV) pneumonia hit a major city of China, Wuhan, December 2019 and subsequently reached other provinces/regions of China and countries.",0.15000000000000002
"The atypical pneumonia case, caused by a novel coronavirus (2019-nCoV), was first reported and confirmed in Wuhan, China in December 31, 2019 [ 1 ].",0.15000000000000002
"While our study was ongoing, a novel lineage B β-CoV was identified as the etiological agent behind an outbreak of pneumonia in Wuhan, Hubei, China (2019-nCoV).",0.15000000000000002
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicatingperson-to-person transmission: a study of a family cluster.,0.15000000000000002
A pneumonia outbreak associated with a new coronavirus of probable bat origin.,0.15000000000000002
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster.,0.15000000000000002
"Finally, we analyze a recently discovered 2019-nCoV coronavirus, which caused a pneumonia outbreak in December 2019 ( Wu et al., 2020 ).",0.15000000000000002
"Background  Since December 29, 2019, pneumonia infection with 2019-nCoV has rapidly spread out from Wuhan, Hubei Province, China to most others provinces and other counties.",0.15000000000000002
"Our findings also suggest that the liver abnormality of 2019-nCoV patients  may  be  caused  by  drug  used  in  the  treatment,  or  systemic  inflammatory  response-induced  by  pneumonias.",0.15000000000000002
"However, Many new compounds generated by our GNC appear to have better druggable propertiesthan these HIV inhibitors do.5 ConclusionWuhan pneumonia outbreak caused by a new coronavirus (CoV), called 2019-nCoV, has led to heavy economicloss and human fatalities.",0.15000000000000002
"While our study was ongoing, a novel lineage B virus tentatively named 2019- nCoV was identified as the cause of a pneumonia outbreak in Hubei, China.",0.15000000000000002
"In  addition,  multiple  studies  have  shown  that antibodies  generated  against  the  N  protein  of  SARS-CoV,  a  highly  immunogenic  and  abundantly expressed protein during infection (Lin et al., 2003), were particularly prevalent in SARS-CoV-infected patients (X Liu et al., 2004; J. Wang et al., 2003).",0.15000000000000002
"Also, wedownloaded all of the available 29 sequences of 2019-nCoV and the bat Betacoronavirus RaTG13 fromthe GISAID platform and two additional sequences (bat-SL-CoVZC45, and bat-SL-CoVZXC21) from theNCBI on January 27, 2019.",0.15000000000000002
"The CGR plots visually suggests and the pairwise distances conﬁrm that thegenomic signature of the 2019-nCoV Wuhan-Hu-1 (Figure 4(a)) is closer to the genomic signature of theBetaCov-RaTG13 (Figure 4(b); distance: 0.0204), followed by the genomic signatures of bat-SL-CoVZC45(Figure 4(c); distance: 0.0417), bat-SL-CoVZXC21(Figure 4(d); distance: 0.0428), Alphacoronavirus/DQ811787 PRCV ISU-1 (Figure 4(e); distance: 0.0672), Gammacoronavirus / Infectious bronchitisvirus NGA /A116E7/2006/FN430415(Figure 4(f); distance: 0.0791), and Deltacoronavirus / PDCoV /USA / Illinois121 /2014/K J481931 (Figure 4(g); distance: 0.0851).The Spearman’s rank correlation coefﬁcient tests were used to further conﬁrm the ML-DSPﬁndings.",0.15000000000000002
Coronaviruses are positive-sense single-stranded RNA viruses belonging to the family Coronaviridae.,0.15000000000000002
"Phylogenetic analysis of coronavirus of different species indicated that 2019-nCoV might have originated from bat, but the intermediate transmission vehicle is not known at this stage.",0.15000000000000002
We show evidence that the novel coronavirus (2019-nCov) is not-mosaic consisting in almost half of its genome of a distinct lineage within the betacoronavirus.,0.15000000000000002
The recently published bat coronavirus sequence however provides strong phylogenetic information to resolve the origin of the Spike protein as well as the rest of the genome suggesting a uniform ancestry across the genome.,0.15000000000000002
"In recent days, domestic and foreign scholars have published research results about new coronaviruses online, and some of them are non-medical scholars who use mathematics and computer technology to simulate and predict disease transmission.",0.15000000000000002
"Using MLDSP andMLDSP-GUI, we conﬁrm that the 2019-nCoV belongs to the Betacoronavirus and its genomic similarityto the sub-genus Sarbecovirus corroborates a possible bat origin.2.",0.15000000000000002
"Here we report the identification and characterization of a novel coronavirus (nCoV-2019) which caused an epidemic of acute respiratory syndrome in humans, in Wuhan, China.",0.15000000000000002
D1772A substitution in the coronavirus papain-like protease Ub-binding sitereduces DUB activity and interferon antagonism without reducing protease activity.,0.15000000000000002
"One domain is coronavirus endopeptidase C30 (CEP_C30), located from 3292 to 3569 of the polyprotein sequence; the other domain is papain like viral protease (PLVP), located from 1564 to 1880 of the sequence.",0.15000000000000002
D1772A  substitution  in  the  coronavirus  papain-like  protease  Ub-binding  site 574 reduces  DUB  activity  and  interferon  antagonism  without  reducing  protease  activity.,0.15000000000000002
"Coronaviruses express a multifunctional papain-like protease, termed PLP2.",0.15000000000000002
"Abstract  Coronaviruses express a multifunctional papain-like protease, termed PLP2.",0.15000000000000002
Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases.,0.15000000000000002
"Furthermore, enzymes displaying deubiquitinating activity are encoded in coronavirus genomes, such as Middle East respiratory syndrome papain-like protease (MERS PLpro) [ 4 ] or severe acute respiratory syndrome papain-like protease (SARS PLpro) [ 5 ].",0.15000000000000002
"The  coronavirus  papain-like  protease  2  (PLP2)  domain  possesses  protease  activity, 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 36 37 38  2 bioRxiv preprint first posted online Sep. 25, 2019; (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.The copyright holder for this preprinthttp://dx.doi.org/10.1101/782409doi: .",0.15000000000000002
"We confirm high sequence similarity (>99%) between all sequenced 2019-nCoVs genomes available, with the closest BCoV sequence sharing 96.2% sequence identity, confirming the notion of a zoonotic origin of 2019-nCoV.",0.15000000000000002
"Besides,  both  2019-nCoV  and  bat CoV clusters share a common ancestor (square), which is supported by 92% bootstrap replications in the phylogeny.",0.15000000000000002
"This nCoV genotype might have been evolved from a bat-CoV by accumulating non-synonymous mutations, indels, and recombination events.",0.15000000000000002
"(D)  The  proportion  of  conserved,  variable  (Single  Nucleotide Polymorphism)  and  INDELs  in  2019-nCoV  was  uncovered  by  aligning  it  to  bat-CoV (left), bat SARS-CoV-like (middle) and human SARS-CoV (right).",0.15000000000000002
"In conclusion, our analysis confirms low variability within the new epidemic virus 2019-nCoV sequenced specimens, while highlighting at least two nucleotide positions of higher variability within protein coding regions,  and  specific  aminoacid  divergences  compared  to  BCoVs  and  SARS  [4].",0.15000000000000002
"The copyright holder for thispreprint (which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.It is made available under a CC-BY-NC 4.0 International license.This  2019-nCoV  strain  might  be  evolved  from  the  bat-CoV  by  accumulating  favorable genetic changes for human infection.",0.15000000000000002
RESULTS AND DISCUSSION Phylogenetic  analysis  reveals  2019-nCoV  closely  related  to  Bat  CoV.,0.15000000000000002
Human SARS  sequences  group  with  Bat  coronavirus  sequences  more  distantly  related  to  2019-nCoV  genomes.,0.15000000000000002
"From phylogenetic analysis of full genome alignment andsimilarity plots, it was found that 2019-nCoV has the highest similarity to the bat coronavirus RaTG13[39].",0.15000000000000002
This was one of the Bat-CoV sequences that were most related to n2019-CoV ( Lu et al.,0.15000000000000002
"We  confirm  high sequence similarity (>99%) between all sequenced 2019-nCoVs genomes available, with the closest BCoV sequence  sharing  96.2%  sequence  identity,  confirming  the  notion  of  a  zoonotic  origin  of  2019-nCoV.",0.15000000000000002
"While 2019-nCoV constitute a tightly similar cluster,  the  two  bat  virus  sequences  MG772934.1  and  EPI_ISL_402131  appear  to  be  linking  the  human 2019-nCoV to the bat coronaviridae.",0.15000000000000002
"This  nCoV  genotype  might  have  been  evolved  from  a  bat-CoV  by accumulating non-synonymous mutations, indels, and recombination events.",0.15000000000000002
"The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health — Thelatest 2019 novel coronavirus outbreak in Wuhan, China.",0.15000000000000002
"The  continuing  2019-nCoV  epidemic  threat  of  novel coronaviruses to global health — The latest 2019 novel coronavirus outbreak in Wuhan, China.",0.15000000000000002
"The continuing 2019-ncov epidemic threat of novel coronaviruses to global health-the latest 2019 novelcoronavirus outbreak in wuhan, china.",0.15000000000000002
"As reported by the World Health Organization, a novel coronavirus (2019-nCoV) was identified as the causative virus of Wuhan pneumonia of unknown etiology by Chinese authorities on 7 January, 2020.",0.15000000000000002
"Like Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), Wuhan pneumonia can also cause severe respiratory disease  [ 4 ] .",0.15000000000000002
Structural studies of coronaviruses have shown that the spike RBD is capable of folding independently from the rest of the spike protein and contains all of the structural information for host receptor binding 15 .,0.15000000000000002
"Therefore, further studies are needed to assess where trypsin is enhancing entry of coronaviruses: at the level of spike, the receptor, or both.",0.15000000000000002
"Structure, function, and evolution of coronavirus spike proteins.",0.15000000000000002
Priming of coronavirus S proteins by host cell proteases is essential for viral entry into cells and protease choice can determine zoonotic potential ( 31 ).,0.15000000000000002
"Interestingly, different regions of the S proteins exhibited different levels of homology among the known coronaviruses ( Fig 1b ).",0.15000000000000002
"Studies have shown that M pro s of difference coronaviruses are highly conserved in terms of both sequences and 3D structures ( Xue et al., 2008 ).",0.15000000000000002
"Coronavirus entry is a multi-step process involving multiple, distinct domains in spike that mediate virus attachment to the cell surface, receptor engagement, protease processing and membrane fusion 8 .",0.15000000000000002
The spike (S) protein of coronaviruses facilitates viral entry into target cells.,0.15000000000000002
Generation of coronavirus spike deletion variants by high-frequency recombination atregions of predicted RNA secondary structure.,0.15000000000000002
Current studies indicate that this coronavirus is similar to SARS and MERS.,0.15000000000000002
The SARS-CoV in 2002-2003 (GenBank accession:  NC_004718 )  and two Bat SARS-like coronavirus isolates bat-SL-CoVZC45 (GenBank accession:  MG772933 )  and bat-SL-CoVZXC21 (GenBank accession:  MG772934 ) were also downloaded for serving as the reference sequences.,0.15000000000000002
"In addition, both ritonavir and lopinavir seemed more suitable to bind to coronavirus endopeptidase C30 than papain like viral protease.",0.15000000000000002
"In this study, we built the structure models of two Wuhan pneumonia coronavirus proteases, coronavirus endopeptidase C30 and papain like viral protease, by homology modeling, followed by docking ritonavir and lopinavir to the protease models, respectively.",0.15000000000000002
This was later attributed to a novel coronavirus deemed 2019-nCoVand represents the third major zoonotic human coronavirus of this century [31].,0.15000000000000002
"In addition, pitavastatin, perampanel, and praziquantel might also have moderate activities against 2019-nCov.",0.15000000000000002
Coronaviruses cause diseases range from common cold to severe pneumonia.,0.15000000000000002
X-ray structural and functional studies of the three tandemly linked domains of non-structural protein 3 (nsp3) from murine hepatitis virus reveal conserved functions.,0.15000000000000002
C. Docking model of lopinavir to 2019-nCoV M pro .,0.15000000000000002
"Left, overall docking model of lopinavir to 2019-nCoV M pro ; middle, enlargement of the lopinavir binding region; right, predicted chemical bonds between lopinavir and key residues of the binding pocket.",0.15000000000000002
"Thus, SARS-CoV was identified in Civet cats and raccoon dogs, which are sold as food sources in Chinese wet markets ( 7 ).",0.15000000000000002
"Next, we expressed and purified several representative SARS-CoV-specific antibodies (Supplementary Methods) which have been reported to target RBD and possess potent neutralizing activities, including m396 [ 3 ], CR3014 [ 4 ], CR3022 [ 5 ], as well as a MERS-CoV-specific human monoclonal antibody m336 developed by our laboratory [ 15 ], and measured their binding ability to 2019-nCoV RBD by ELISA (Supplementary Methods,  Figure 1e ).",0.15000000000000002
"Very recently, a novel beta-CoVs Coronavirus (2019-nCoV) originating from the province of Wuhan, China, has been causally linked to  severe respiratory infections in humans.",0.15000000000000002
"The coronaviruses are positive-sense, single strand RNA viruses, and thus share properties with other single-stranded RNA viruses such as hepatitis C virus, West Nile virus, Marburg virus, HIV virus, Ebola virus, dengue virus, and rhinoviruses.",0.15000000000000002
"The nCoV-2019 virus was then isolated 37 from the bronchoalveolar lavage fluid of a critically ill patient, which can be 38 neutralized by sera from several patients.",0.15000000000000002
"Different from other human-derived coronaviruses, SARS-CoV leads to severe acute respiratory syndrome (SARS), with a fatality rate of up to ∼10%.",0.15000000000000002
The  genome  sequences  of  2019-nCoV  were  obtained  on  29  January  2020 along  with  genetically  related  10  SARS-CoV/SARS-CoV-like  virus  genome  sequences that we identified through the BLASTN search in NCBI database.,0.15000000000000002
"It was generally believed that SARSr-CoV, mainly found in bats, might cause future disease outbreak10,11.",0.15000000000000002
"Background  The 2019 new coronavirus, “2019-nCoV”, was discovered from Wuhan Viral Pneumonia cases in December 2019, and was named by the World Health Organization on January 12, 2020.",0.15000000000000002
"The 2019 new coronavirus, “2019-nCoV”, was discovered from Wuhan Viral Pneumonia cases in December 2019, and was named by the World Health Organization on January 12, 2020.",0.15000000000000002
"While the four 2019-nCoVs have no SNPs on the two predicted ORFs, they have two nonsynonymous SNPs on ymdB, which indicates that these 2019-nCoV may derived from one origin.",0.15000000000000002
"Whenanalyzing the conserved replicase domains of ORF1ab for coronavirus species classiﬁcation, nearly94% of amino acid residues were identical to SARS-CoV, yet overall genome similarity was onlyaround 70%, conﬁrming that 2019-nCoV was genetically different [63].",0.15000000000000002
The result revealed that the similarity between the region at 3264 ∼ 3570 aa of 2019-nCoV ORF1 ab protein and SARS-CoV main protease 5n5o was up to 96.1% ( Fig.,0.15000000000000002
"The predicted replicase ORF1ab gene of WHCV is 21,291 nt in length and contained 16 predicted non-structural proteins (Table S4), followed by (at least) 13 downstream ORFs.",0.15000000000000002
The blast results of ORF1ab of 2019-nCoV against SARS-CoV main proteases.,0.15000000000000002
"In this study, we built two models of two protease-like domains, CEP_C30 and PLVP, of orf1ab polyprotein of Wuhan pneumonia coronavirus.",0.15000000000000002
"MERS-CoV has infected 2,494 individuals in 27 countries since 2012, 858 of them died  ( 17 ) .",0.15000000000000002
"In previous studies, a number of potent monoclonal antibodies against SARS coronavirus (SARS-CoV) have been identified [ 3 - 7 ].",0.15000000000000002
The binding model of nelfinavir against 2019-CoV M pro .,0.15000000000000002
The results showed that the binding site between Nelfinavir and the main protease was located at the joint groove ( Fig.,0.15000000000000002
"Among them, Prulifloxacin exhibited three binding sites with main protease, two of which were the same as Nelfinavir and Bictegravir.",0.15000000000000002
"As shown in  Figure 2 , the binding model of nelfinavir in its docking complex turned out to be very similar with that of the original ligand (TG-0205221) 25  of 2GX4 ( Figure 2a & b ), which is an inhibitor of SARS M pro  with in vitro Ki of 0.053 μM and IC50 of 0.6 μM in the Vero-E6 cells.",0.15000000000000002
"The binding energy between Nelfinavir and major protease was −8.6 kcal/mol, but the estimated affinity seemed not high enough ( Fig.",0.15000000000000002
"(E) Sequence alignment (MultAlign) of coronavirus 555 papain-like  protease/deubiquitinating  domains from  MHV (1606-1911  aa,  accession 556 #AAX23975), SARS (1541-1854 aa, accession #ACZ72209), 2019-nCoV (1564-1878, accession 557 #QHO60603) and MERS (1480-1803 aa, accession # AHY21467).",0.15000000000000002
"(E) Sequence alignment (MultAlign) ofcoronavirus papain-like protease/deubiquitinating domains from MHV (1606-1911 aa, accession#AAX23975), SARS (1541-1854 aa, accession #ACZ72209), 2019-nCoV (1564-1878, accession#QHO60603) and MERS (1480-1803 aa, accession # AHY21467).",0.15000000000000002
"X-ray  structural  studies  of  SARS-  and  MERS-CoV  papain-like  protease/DUBs  co-crystalized with ubiquitin modified at the c-terminus with a covalent warhead (aldehyde, 3-bromo-propylamine, or propargylamine) allowed for identification of residues that are important for direct interaction with ubiquitin (17, 18, 20).",0.15000000000000002
"Next, we aligned the  primary  amino acid  sequence of the  MHV PLP2 domain  with  the SARS-CoV and MERS-CoV papain-like protease domains (Fig.",0.15000000000000002
"MHV PLP2 is similar to the single papain-like protease (termed PLpro) of Severe Acute Respiratory  Syndrome  Coronavirus  (SARS-CoV)  and  Middle  East  Respiratory  Syndrome Coronavirus  (MERS-CoV)  (9,  12–16).",0.15000000000000002
Crystal structure of the MERS coronavirus papain-like protease bound to ubiquitin facilitates targeted disruption of deubiquitinating activity to demonstrate its role in innate immune suppression.,0.15000000000000002
MERS-CoV papain-like protease has deISGylating and deubiquitinating activities.,0.15000000000000002
X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design.,0.15000000000000002
Catalytic function and substrate specificity of the papain-like protease domain of nsp3 from the Middle East respiratory syndrome coronavirus.,0.15000000000000002
Assessing Activity and Inhibition of MERS-CoV Papain-like and 3C-like Proteases Using Luciferase-based Biosensors.,0.15000000000000002
"Based on the molecular mechanisms  of  blocking  of  ACE2, the  fusion  proteins have  the  potential  to  have  broad neutralizing activity to coronavirus.",0.15000000000000002
"Crystal structure of SARS-CoV M pro  (PDB ID: 1UJ1) was downloaded from Protein Data Bank (PDB,  http://www.rcsb.org ) ( Burley et al., 2019 ).",0.15000000000000002
"An overview of SARS-CoV 3CL protease inhibitors has been reported.16 However,currently, there are no effective anti-SARS-CoV drugs available despite there are more than 3500 publications.It is true that there were only 8422 infected cases and 916 deaths reported for SARS-CoV, which might makethe drug development unproﬁtable.",0.15000000000000002
An overview of severe acute respiratory syndrome–coronavirus (sars-cov) 3cl protease inhibitors:Peptidomimetics and small molecule chemotherapy.,0.15000000000000002
We downloaded the sequences of a total of 103 SARS-CoV main proteases with different origins from PDB and built a local library for homology alignment.,0.15000000000000002
Binding pockets and functional sites of SARS-CoV main protease A: Dimer structure; B: Monomer structure; C: Detected pockets.,0.15000000000000002
The structures and sequences of SARS-CoV main protease were downloaded from PDB database.,0.15000000000000002
"The viral genome organization of WHCV was characterized by sequence alignment against two representative members of the genus  Betacoronavirus : a human-origin coronavirus (SARS-CoV Tor2, AY274119) and a bat-origin coronavirus (Bat-SL-CoVZC45, MG772933) ( Figure 2 ).",0.15000000000000002
"Specifically, in the S gene tree (Figure S4), WHCV was most closely related to the bat coronavirus bat-SL-CoVZC45 with 82.3% amino acid (aa) identity (and ∼77.2% aa identity to SARS CoV; Table S3), while in the ORF1b phylogeny WHCV fell in a basal position within the subgenus  Sarbecovirus  ( Figure 3 ).",0.15000000000000002
"The MoDMap3D generated from the Test-5 (Figure2(b)) visually suggests and the average distances from 2019-nCoV sequences to all other sequencesconﬁrm that the 2019-nCoV sequences are most proximal to the RaTG13 (distance: 0.0203), followedby the bat-SL-CoVZC45 (0.0418), and bat-SL-CoVZX21 (0.0428).",0.15000000000000002
"The phylogenetic tree placed the RaTG13 sequence closest to the 2019-nCoV sequences,followed by the bat-SL-CoVZC45 and bat-SL-CoVZX21 sequences.",0.15000000000000002
Detection of novel SARS-like and other coronaviruses in bats from Kenya.,0.15000000000000002
"It is made available under a CC-BY 4.0 International license.perpetuity.7 of 22Given conﬁrmation that the 2019-nCoV belongs to the Betacoronavirus genus, there now is aquestion of its origin and relation to the other viruses of the same genus.",0.15000000000000002
"Like SARS-CoV and MERS-CoV, the recent 2019-nCoV belongs to the Betacoronavirus genus (Lu et al., 2020).",0.15000000000000002
"The possible reason is that this isolation is only implemented for I-status users, but one of the characteristics of 2019-nCoV is that not only I-status is contagious, but E-status is also contagious.",0.15000000000000002
"Gralinski, L. E. and Menachery, V. D. Return of the Coronavirus: 2019-nCoV.",0.15000000000000002
"Under the assumptions that the imported case is representative of the patients in China, and that the 2019-nCoV is similarly transmissible to the SARS coronavirus, the probability that an imported case is followed by sustained human-to-human transmission is 0.37.",0.15000000000000002
"3C ), demonstrating that 2019-nCoV-S uses TMPRSS2 for priming.",0.15000000000000002
"4B , the binding energy between Bictegravir and major protease was −8.3 kcal/mol at the joint groove, but only −7.3 kcal/mol at the active site, and the estimated affinity is satisfied ( Fig.",0.15000000000000002
"As  previously observed,  the  N  protein  in  2019-nCoV  differs  from  the  SARS  ortholog  in  the  structurally  relevant aminoacids 380 and 410 [4].",0.15000000000000002
Novel Coronavirus (2019-nCoV) 2020 [cited 2020 January 27].,0.15000000000000002
Diversity of coronavirus in bats from Eastern Thailand Emerging viruses.,0.15000000000000002
"An outbreak of a novel coronavirus (2019-nCoV) was reported in Wuhan, a city in central China (WHO).",0.15000000000000002
"Only a few days later, Chinese authorities identified and characterised a novel coronavirus (2019-nCoV) as the causative agent of the outbreak [ 2 ].",0.15000000000000002
Background  The current outbreak caused by novel coronavirus (2019-nCoV) in China has become a worldwide concern.,0.15000000000000002
"2019-nCoV, novel coronavirus, Wuhan pneumonia, healthcare system, mathematical Keywords modelling     - 2 -bioRxiv preprint first posted online Jan. 28, 2020; doi: http://dx.doi.org/10.1101/2020.01.27.922443.",0.15000000000000002
"Additionally, WHCV shares a highly conserved domain (LLRKNGNKG: amino acids 122-130) with SARS-CoV in nsp1.",0.15000000000000002
"Coronaviruses (CoV) (order Nidovirales, family Coronaviridae) are enveloped, positive stranded RNA viruses, which includes 4 genera  Alphacoronavirus  (α-CoV),  Betacoronavirus  (β-CoV),  Gammacoronavirus  (γ-CoV), and  Deltacoronavirus  (δ-CoV) [ 1 , 2 ].",0.15000000000000002
"Human 2019-nCoV are shown as blue circles, other genomes as grey diamonds.",0.15000000000000002
"All constructs exhibited similar levels of expression in producer cells and incorporation into VSV pseudotypes, except the chimera with BM48-31 which displayed somewhat reduced expression compared to WT SARS spike ( figure 1d ).",0.15000000000000002
We chose VSV over lentiviruses as our pseudotype platform because a lentiviral pseudotypes have failed to accurately reflect viral entry with novel bat coronavirus spike protein 7 .,0.15000000000000002
"By Jan 28, 2020, more than 4500 patients were confirmed to be infected with 2019-nCoV, and nearly 100 patients were died from the infection.",0.15000000000000002
"Daily reported incidence of confirmed 2019-nCoV cases, death, and recovery in China is available from 11th January, 2020.",0.15000000000000002
"Therefore, these results suggest that 2019-nCoV may representa genetically distinct species of Sarbecovirus.",0.15000000000000002
"It turns out that six genomes of 2019-nCoV all have a high possibility ( p-value <0.05) to infect human (as shown in  Table 1 , and Table S2).",0.15000000000000002
Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus.,0.15000000000000002
The papain-like protease determines a virulence trait that varies among members of the SARS-coronavirus species.,0.15000000000000002
The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme.,0.15000000000000002
The papain-like 446 protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity.,0.15000000000000002
Recognition of Lys48-Linked Di-ubiquitin and Deubiquitinating Activities of the SARS Coronavirus Papain-like Protease.,0.15000000000000002
Structural basis for the ubiquitin-linkage specificity and deISGylating activity of SARS-CoV papain-like protease.,0.15000000000000002
"In fact, our recent studies using 265 SARS-CoV  and  SARS-related  CoVs  found  that  the  papain-like  protease  domain/DUB  is  a 266 virulence trait that varies among members of the SARS-coronavirus species (4).",0.15000000000000002
Genetic linkage analysis showed that 2019-nCoV lied at the interface between bat SARS like coronavirus and bat coronavirus and should belong to a novel type of bat coronavirus owing to high degree of variation from the human SARS virus.,0.15000000000000002
These data further suggested that 2019-nCoV is more likely a new type of bat coronavirus with only loose linkage with the SARS virus.,0.15000000000000002
"It is made available under a perpetuity.CC-BY-NC-ND 4.0 International license.Abstract A  newly  identified  coronavirus,  2019-nCoV,  has  been  posing  significant  threats  to  public health  since  December  2019.",0.15000000000000002
"In December 2019, a novel CoV (2019-nCoV) emerged from Wuhan, China, and spread rapidly to other  areas(Holshue  et  al.,  2020;  Li  et  al.,  2020; Wu  et  al.,  2020;  Zhou  et  al.,  2020).",0.15000000000000002
"c , VSV pseudotypes were generated with the indicated RBD and used to infect BHKs transfected with either human ACE2 or empty vector.",0.15000000000000002
Phylogenetic analysis of genomic sequences of coronaviruses deposited in the GenBank revealed that 2019-nCoV belonged to betacoronavirus and exhibited the closest linkage with two SARS-like coronavirus from bat (bat-SL-CoVZX45 and bat-SL-CoVZX21) ( Fig 1a ).,0.15000000000000002
"Over the past 20 years, several coronaviruses have crossed the species barrier into humans, causing outbreaks of severe, and often fatal, respiratory illness.",0.15000000000000002
"The previously known virus that is most similar to the 2019-nCoV is the SARS coronavirus [ 9 ], which generated cases in 37 countries in 2002-03 [ 9 , 10 ].",0.15000000000000002
"Coronaviruses  are  single  positive-stranded  RNA  viruses  belonging  to  Coronaviridae family1,  which  are  divided  into  four  genera:  Alpha-,  Beta-,  Delta-  and  Gamma-coronavirus.",0.15000000000000002
The 2019-nCoV is significantly closely related only to the specific Bat SARS-like coronavirus isolated from Rhinolophus sinicus in 2015 in China (MG772934.1) ( Figure 1 ).,0.15000000000000002
"The phylogenetic tree showed that 2019.nCoV significantly clustered with Bat SARS-like Coronavirus sequence isolated in 2015, whereas structural analysis revealed mutation in S and nucleocapsid proteins.",0.15000000000000002
"On the 644th aminoacidic position in 2019-nCoV sequence there is a threonine residue while the Bat SARS-like virus has a serine residue, instead the SARS virus has an alanine residue The data reported above show that the new 2019-nCoV significantly clustered with a sequence from the Bat SARS-like Coronavirus isolated in 2015.",0.15000000000000002
"Besides, compared with the two Bat SARS-like Coronaviruses, 2019-nCoVs have 4, ∼130, ∼220 nonsynonymous SNPs on the three core genes respectively, which shows the differences among 2019-nCoV and SARS-CoV-like Coronaviruses.",0.15000000000000002
The further structural and molecular analysis of the Nucleocapsid region of the 2019-nCoV (MN908947.3) has highlighted that 2019-nCoV and the Bat SARS-like coronavirus (MG772934.),0.15000000000000002
"A phylogenetic tree has been built using the 15 available whole genome sequence of 2019-nCoV and 12 whole genome sequences highly similar sequences available in gene bank (5 from SARS, 2 from MERS and 5 from Bat SARS-like Coronavirus).",0.15000000000000002
"Unexpectedly, the world is facing the same situation as the previous outbreak due to a recent epidemic of atypical pneumonia caused by a novel coronavirus (2019-nCoV) in Wuhan, China ( 5 ,  9 ).",0.15000000000000002
"Cluster 4 ( Bat SARS-CoV ZXC21/ZC45 ) includes two SARSr-CoV sampled from Rhinolophus sinicus bats in Zhoushan, China.",0.15000000000000002
"We  found  a  bat  CoV  genome (Gisaid  EPI_ISL_402131)  with  96.2%  sequence  identity  (and  query  coverage  above  99%)  to  the  2019-nCoV reference sequence (NC_045512.2), while the previously reported closest bat CoV (bat-SL-CoVZC45) has  a  sequence  similarity  of  88%  [6].",0.15000000000000002
Our analysis confirms previous results highlighting the  Bat  coronavirus  as  a  likely  evolutionary link  between  the  SARS  viruses  and the  current epidemic  2019-nCoV  [4].,0.15000000000000002
"Two  specific  specimens  gathered  in  2013  and  2015  in  China  from  the  bat  species Rhinolophus  affinis  and  Rhinolophus  sinicus  appear  to  be  located  between  the  Bat  coronavirus  and  the human 2019-nCoV groups, supporting the notion of a zoonotic transfer from bats to humans [4].",0.15000000000000002
"Among the SARS viruses, bat coronaviruses and 2019-nCoV, the non-structural proteins generally aligned well but variations were observable in major structural proteins and some small ORFs ( Fig 1b ).",0.15000000000000002
"Timely identiﬁcation of taxonomic classiﬁcation at criticalperiods exempliﬁed by viral outbreaks is important and alignment-free approaches to comparativegenomics complement the challenges and time-consuming attributes of alignment-based analyses.We corroborate the current hypothesis of a bat origin and classify 2019-nCoV as Sarbecovirus, withinBetacoronavirus.",0.15000000000000002
"This shows thatalthough 2019-nCoV and Sarbecovirus are closer on the basis of genomic similarity (Test-4), they are stilldistinguishable from known species.",0.15000000000000002
Our objectives were to characterize the genetic relationships of the 2019-nCoV and to search for putative recombination within the subgenus of sarbecovirus.,0.15000000000000002
Thissuggests substantial similarity between 2019-nCoV and the Sarbecovirus sequences.,0.15000000000000002
"The virus, which has received the placeholder name 2019-nCoV, turns out to be a new member of the subgenus sarbecovirus, in the Orthocoronavirinae subfamily, but is distinct from MERS CoV and SARS CoV ( Zhu et al 2020 ).",0.15000000000000002
"Genome data for 2019-nCoV made kindly available by National Institute for Communicable Disease Control and Prevention (ICDC) Chinese Center for Disease Control and Prevention (China CDC), Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, Hubei Provincial Center for Disease Control and Prevention, Wuhan Institute of Virology, Chinese Academy of Sciences, National Institute for Viral Disease Control and Prevention, China CDC, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Department of Medical Sciences, Ministry of Public Health, Thailand | Thai Red Cross Emerging Infectious Diseases - Health Science Centre | Department of Disease Control, Ministry of Public Health, Thailand, Department of Microbiology, Guangdong Provincial Center for Diseases Control and Prevention, Department of Microbiology, Zhejiang Provincial Center for Disease Control and Prevention, Division of Viral Diseases, Centers for Disease Control and Prevention, Centers for Disease Control, R.O.C.",0.15000000000000002
"The identification of multiple SARS-like-CoVs in bats led to the idea that these animals act as the natural reservoir hosts of these viruses 19 ,  20 .",0.15000000000000002
"Withwidespread geographic coverage, SARS-like coronaviruses have likely been present in bats for a longperiod of time and novel strains of these coronaviruses can arise through recombination [4].",0.15000000000000002
There is still ongoing debate whetherthe 2019-nCoV strain arose following recombination with previously identiﬁed bat and unknowncoronaviruses [40] or arose independently as a new lineage to infect humans [39].,0.15000000000000002
"This suggested that 2019-nCoV is the species of SARS related coronaviruses (SARSr-CoV) by pairwise protein sequence analysis[ 2 ,  3 ].",0.15000000000000002
"From these results, 2019nCoV could be considered a coronavirus distinct from SARS virus, probably transmitted from bats or another host where mutations conferred upon it the ability to infect humans.",0.15000000000000002
"Recently, a new coronavirus (2019-nCoV), has emerged in the region of Wuhan (China) as a cause of severe respiratory infection in humans.",0.15000000000000002
"EPI_ISL_402124) [ 2 ], 2019-nCoV belongs to lineage B betacoronavirus and shares high sequence identity with that of bat or human severe acute respiratory syndrome coronavirus-related coronavirus (SARSr-CoV) and bat SARS-like coronavirus (SL-CoV) ( Figure 1a ).",0.15000000000000002
"Coronavirus 2019-nCoV aligned best with the bat SARS-like virus bat-SL-CoVZX45, with the majority of genetic variations being seen at the N-terminal part of S protein.",0.15000000000000002
"Initiatives to identify the source oftransmission and possible intermediate animal vectors have commenced since the genome sequencebecame publicly available.From analyses employing whole genome to viral protein-based comparisons, the 2019-nCoVstrain is thought to belong to lineage B (Sarbecovirus) of Betacoronavirus.",0.15000000000000002
"Some of the largest sources of diversity for coronaviruses belong to the strains thatinfect bats and birds, providing a reservoir in wild animals for recombination and mutation that mayenable cross-species transmission into other mammals and humans [4,7,8,10,13].Like other RNA viruses, coronavirus genomes are known to have genomic plasticity, and this canbe attributed to several major factors.",0.15000000000000002
"A 29-bp insertion in ORF 8 of bat-SARS-CoV genome, not found in most human SARS-CoV genomes, was suggestive of a common ancestor with civet SARS-CoV [ 8 ].",0.15000000000000002
"Coronaviruses (CoVs), belonging to the family  Coronaviridae , are positive-sense enveloped RNA viruses and cause infections in birds, mammals, and humans ( 1 – 3 ).",0.15000000000000002
2019-nCoVs are the pathogens that cause severe pneumonia in human in Wuhan recently.,0.15000000000000002
"Furthermore, it was found that nCoV-2019 is 96% identical at the whole genome level to a bat coronavirus.",0.15000000000000002
"Since the current outbreak is originated from Wuhan city of  China,  we  set  out  to  study  the  2019-nCoV  epitopes  displayed  by  HLA-DR  alleles predominantly present in the ethnic populations of China (PRC), Thailand (TH), Japan (JPN) and Asia-Pacific Region (APR).",0.15000000000000002
"Generally, we could observe a high conservation for structural proteins E, M and A across the beta-coronavirus family, while accessory proteins (especially ORF8) seem to have much stricter evolutionary constraints (Table 1).",0.15000000000000002
"Key words: 2019-nCoV; Coronavirus; Evolution; Genome: Structural Proteins; Epitopes;      Vaccine Target INTRODUCTION Page 2 of 15 bioRxiv preprint first posted online Jan. 30, 2020; doi: http://dx.doi.org/10.1101/2020.01.29.925867.",0.15000000000000002
"Detailed genomic and structure-based analysis of a new coronavirus, namely 2019-nCoV, showed that the new virus is a new type of bat coronavirus and is genetically fairly distant from the human SARS coronavirus.",0.15000000000000002
"Among all know RNA viruses, coronaviruses have the largest genomes ranging from 26 to 32 kb in length ( Regenmortel et al., 2000 ;  Schoeman and Fielding, 2019 ).",0.15000000000000002
A new coronavirus associated with human respiratory disease in China.,0.15000000000000002
A new coronavirus associated with human respiratory disease in China.,0.15000000000000002
"The infection of a novel coronavirus found in Wuhan of China (2019-nCoV) is rapidly spreading, and the incidence rate is increasing worldwide.",0.15000000000000002
The second test (Test-2)is designed to classify 2019-nCoV among the families of the Riboviria realm.,0.15000000000000002
"Complete genome characterisation of a novel coronavirus associated with severe humanrespiratory disease in Wuhan, China.",0.15000000000000002
Background  A novel coronavirus (2019-nCoV) associated with human to human transmission and severe human infection has been recently reported from the city of Wuhan in China.,0.15000000000000002
"Many novel SARS-like coronaviruses have been discoveredin bats across China, and even in European, African and other Asian countries [35,70–76].",0.15000000000000002
"Hexbin scatterplots of the proportional k-mer (k = 7) frequencies of the 2019-nCoV sequencesversus the four sub-genera: (a) Embecovirus, ρ = 0.59; (b) Merbecovirus, ρ = 0.64; (c) Nobecovirus, ρ= 0.54 and (d) Sarbecovirus, ρ = 0.72.",0.15000000000000002
All of the classiﬁcation modelstrained on the dataset in Test-4 predicted the label of all 29 2019-nCoV sequences as Sarbecovirus.,0.15000000000000002
"However, WHCV changed topological position within the subgenus  Sarbecovirus  depending on which gene was used, suggestive of a past history of recombination in this group of viruses ( Figures 3  and S4).",0.15000000000000002
"As for the clinical manifestations of 2019-nCoV infection, fever and cough are most common symptoms at onset[ 4 ,  5 ].",0.15000000000000002
Possible recombination events in the S gene of sarbecoviruses.,0.15000000000000002
Ever since both SARS and MERS-CoV (due to their high case fatality rates) are prioritized together with “highly pathogenic coronaviral diseases other than MERS and SARS” under the Research and Development Blueprint published by the WHO [ 16 ].,0.15000000000000002
"However, bat SARS-like CoV Rp Shaanxi2011 exhibited high homology with human SARS virus ZJ02, with variation being seen at the N-terminus of S protein and the middle part of N protein ( Fig 1b ).",0.15000000000000002
"Our data showed that the S protein of 2019-nCoV exhibited high homology with bat SARS-like coronaviruses such as bat-SL-CoVZX45 and bat-SL-CoVZX21, human SARS virus and bat coronaviruses.",0.15000000000000002
"Another bat-originated coronavirus, bat SARS CoV W1V1 that displayed strong binding to ACE2 and exhibited potential to cause human infection was also included for analysis.",0.15000000000000002
"By core gene and accessary gene analysis of the left four 2019-nCoVs and the two Bat SARS-like Coronaviruses, we found three core genes: two ORFs and one functional gene ymdB.",0.15000000000000002
"(c) Protein sequence alignment of 2019-nCoV and SARS-CoV RBD, showing the predominant residues that contribute to interactions with SARS-CoV-specific antibodies.",0.15000000000000002
This analysis suggests that some SARS-CoV-specific monoclonal antibodies may be effective in neutralizing 2019-nCoV.,0.15000000000000002
"We predicted the conformation of 2019-nCoV RBD as well as its complex structures with several neutralizing antibodies (Supplementary Methods), and found that the modelling results support the interactions between 2019-nCoV RBD and certain SARS-CoV antibodies ( Figure 1b ).",0.15000000000000002
Coronavirus is a group of positive single-stranded RNA virus with coronary appearance  [ 1 ] .,0.15000000000000002
"Coronaviruses frequently undergo recombination, gaining large swaths of genetic material at once  34 ,  35 .",0.15000000000000002
The first case of MERS-CoV occurred in Saudi Arabia in 2012.,0.15000000000000002
"In November 2002, SARS-CoV found its first victim in Foshan, mainland China, and soon spread to all over the country by travelling with potential patients  ( 9 ) .",0.15000000000000002
There is rising global concern for the recently emerged novel Coronavirus (2019-nCov).,0.15000000000000002
D. Docking model of colistin to 2019-nCoV M pro .,0.15000000000000002
"Left, overall docking model of colistin to 2019-nCoV M pro ; right, predicted chemical bonds between colistin and key residues of the binding pocket.",0.15000000000000002
Report 3: Transmissibility of 2019-nCoV.,0.15000000000000002
"Similarly, the antibody m396, which was predicted to bind 2019-nCoV RBD ( Figure 1d ), only showed slight binding at the highest measured concentration (2 µM).",0.15000000000000002
"The coronaviruses is the common infection source of upper respiratory, gastrointestinal and central nervous system in humans and other mammals[ 19 ].",0.15000000000000002
"For instance, residues in RBD of SARS-CoV that make polar interactions with a neutralizing antibody m396 as indicated by the complex crystal structure [ 10 ] are invariably conserved in 2019-nCoV RBD ( Figure 1d ).",0.15000000000000002
"Coronaviruses resistant to a 3C-like protease inhibitor are attenuated for replication and pathogenesis, revealing a low genetic barrier but high fitness 541 542 543 cost of resistance.",0.15000000000000002
"There are concerns that the ongoing outbreak driven by 2019-nCoV could spread globally [ 3 , 5 , 19 , 20 ] with sustained transmission in countries around the world.",0.15000000000000002
"b, dynamics of nCoV-2019 antibodies in one patient 255 who showed sign of disease on 2019.12.23 (ICU-06).",0.15000000000000002
"Compared to lopinavir/ritonavir, most of these predicted drugs could form more hydrogen bounds with 2019-nCoV M pro , thus may have higher mutation tolerance than lopinavir/ritonavir.",0.15000000000000002
"Virtual docking of lopinavir/ritonavir to 2019-nCoV M pro  also showed high binding ability to the pocket site ( Figure 1c ), similar to previous report for SARS-CoV M pro  ( Nukoolkarn et al., 2008 ).",0.15000000000000002
Structural comparison of lopinavir/ritonavir binding pocket in SARS-CoV M pro  and 2019-nCoV M pro .,0.15000000000000002
"Furthermore, all of the 47 2019-nCoV WGS that were isolated in China (n=36), USA (n=5), France (n=2), Thailand (n=2), Japan (n=1) and Taiwan (n=1) were correctly classified at phylogenetic cluster level as 2019-nCoV, which may be renamed as SARS-B.",0.15000000000000002
"Though 2019-nCoV has a death rate of 2.2% as of 3 February, the 174895 confirmed cases in a few weeks (December 8, 2019 to February 3, 2020) are alarming.",0.15000000000000002
"Though 2019-nCoV has a death rate of 2.2% as of 3 February, the 17489conﬁrmed cases in a few weeks (December 8, 2019 to February 3, 2020) are alarming.",0.15000000000000002
"To the best of our knowledge, there is no existing peer-reviewed literature quantifying the transmissibility of 2019-nCoV as of January 22, 2020.",0.15000000000000002
"However, some evidence for past recombination was detected in the S gene of WHCV and SARS CoV and bat SARS-like CoVs (WIV1 and RsSHC014) (p<3.147×10 -3  to p<9.198×10 -9 ), with similarity plots suggesting the presence of recombination break points at nucleotides 1,029 and 1,652 that separated the WHCV S gene into three regions ( Figure 5 ).",0.15000000000000002
Genetic Characterization of Betacoronavirus Lineage C Viruses in Bats Reveals MarkedSequence Divergence in the Spike Protein of Pipistrellus Bat Coronavirus HKU5 in Japanese Pipistrelle:Implications for the Origin of the Novel Middle East Respiratory Syndrome Coronavirus.,0.15000000000000002
"The 2019-nCoV stands in a position between bat SARS-like viruses and bat coronaviruses, suggesting it is less related to the human SARS virus than other bat SARS-like viruses, and is likely a new type of bat coronavirus.",0.15000000000000002
"As visually suggested bythe MoDMap3D (Figure 2(b)), the average inter-cluster distances conﬁrm that the 2019-nCoV sequencesare closest to the Sarbecovirus (average distance 0.0556), followed by Merbecovirus (0.0746), Embecovirus(0.0914), and Nobecovirus (0.0916).",0.15000000000000002
The  novel coronavirus was isolated from the airway epithelial cells of patients with pneumonia that was epidemiologically linked to Huanan seafood market in Wuhan.,0.15000000000000002
"On 6 th  January 2020, the Chinese authority released the sequence (accession#:  MN908947 ) of a novel coronavirus, designated as 2019-nCoV, which was isolated from one of the pneumonia patients and confirmed to be the causative agent for this outbreak.",0.15000000000000002
"An amino acid sequence alignment of WHCV, SARS-CoVs, bat SARS-like CoVs RBD sequences was performed using MUSCLE 35 .",0.15000000000000002
Various  reports  related  to  SARS-CoV  suggest  a  protective  role  of  both  humoral  and  cell-mediated immune responses.,0.15000000000000002
"The strongest correlation value was found between Betacoronavirus and Sarbecovirus whenusing the data sets from Test 3a from Table 2 and Test 4 from Table 3, respectively.DatasetTest-3aTest-4Comparison Groups2019-nCoV vs.ρ valueAlphacoronavirusBetacoronavirusGammacoronavirusDeltacoronavirusEmbecovirusMerbecovirusNobecovirusSarbecovirus0.700.740.630.600.590.640.540.724.",0.15000000000000002
"Further examination of interactions between RBD from bat SARS like coronaviruses, bat-SL-CoVZX45 and Rp Shaanxi2011 that do not infect human, showed only one cation-π interaction interaction, ACE2(K 353 )/ RBD(Y 481 ).",0.15000000000000002
"Along withthe phylogenetic data, the genome organization of 2019-nCoV was found to be typical of lineageB (Sarbecovirus) Betacoronaviruses [34].",0.15000000000000002
NovelCoronavirus(2019-nCoV)online:https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200202-sitrep-13-ncov-v3.pdf(accessed on 02 February 2020).AvailableSituationReport13.-34.,0.15000000000000002
"Snakes had been proposed as an intermediary hostfor 2019-nCoV based on relative synonymous codon usage bias studies between viruses and their hosts[40], however, this claim has been disputed [78].",0.15000000000000002
"These sequence alignment data were consistent with results of phylogenetic tree analysis and indicated that 2019-nCoV exhibited stands in between bat SARS like viruses and bat coronaviruses, but is genetically distant from the human SARS virus.",0.15000000000000002
"Phylogenetic studies have revealed a complex evolutionary history, withcoronaviruses thought to have ancient origins and recent crossover events that can lead to cross-speciesinfection [8,10–12].",0.15000000000000002
HIVs pseudotyped with the S glycoprotein from CoVs  were  incubated  with  different fusion  proteins  for 1 h before  infection.,0.15000000000000002
Murine coronavirus ubiquitin-like domain is important for papain-like protease stability and viral pathogenesis.,0.15000000000000002
"Notably, one SARS-CoV-specific antibody, CR3022, was found to bind potently with 2019-nCoV RBD as determined by ELISA and BLI ( Figure 1e, 1f ).",0.15000000000000002
Quantitative evidence supports classiﬁcation of2019-nCoV within the Betacoronavirus genus proximal to the Sarbecovirus sub-genus.,0.15000000000000002
"Here, we present The Genome Detective Coronavirus Typing Tool that can accurately identify novel coronavirus (2019-nCoV) sequences isolated in China and around the world.",0.15000000000000002
(B)  Evolution  of  a  2019-nCoV virus  from  bat/unknown  animals  to  humans  and  spread  among  humans.,0.15000000000000002
This  human  pathogen  is  a  member  of  betacoronavirus  genus carrying  30  kilobase  of  single  positive-sense  RNA  genome.,0.15000000000000002
"Based on the information we known, we assumed that the 2019-nCoV might be imported to the seafood market in a short time.",0.15000000000000002
Mutation in spike protein cleavage site and pathogenesis of feline coronavirus.,0.15000000000000002
"Coronaviruses are a large family of viruses, most of which cause mild infections such as the common cold, but some such as the SARS and MERS (Middle East Respiratory Syndrome) viruses cause severe and potential fatal respiratory tract infections.",0.15000000000000002
"In this study, we applied a modified SIR model to evaluate the burden of healthcare system during the 2019-nCoV outbreak in Wuhan, China.",0.15000000000000002
"The genome organization  for  coronaviruses  is  highly  conserved,  with  the  5’-most  two-thirds  of  the  genome encoding  the  replicase  polyprotein,  followed  by  sequences  encoding  the  canonical  structural proteins:  spike,  envelope,  membrane,  and  nucleocapsid.",0.15000000000000002
"The virus (2019-nCoV) has spread elsewhere in China and to other countries, including South Korea, Thailand, Japan and USA.",0.15000000000000002
"As expected, allclassiﬁcation models correctly predict that the 2019-nCoV sequences belong to the Riboviria realm,see Table 2.",0.15000000000000002
"Coronaviruses arealso known to use a template switching mechanism which can contribute to high rates of homologousRNA recombination between their viral genomes [9,16–20].",0.15000000000000002
"Both  viruses  are  of  zoonotic  nature:  SARS-CoV  originates  from bats/civet cats(Ge et al., 2013), and the major reservoir for MERS-CoV is dromedary camels(Reusken et al., 2016).",0.15000000000000002
"The fact that the RBD of 2019-nCoV exhibited much lower affinity to ACE2 implies that the virulence potential of 2019-nCoV should be much lower than that of human SARS virus, but is nevertheless stronger than viruses that do not cause human infection; such finding is also consistent with the current epidemiological data in that 2019-nCoV only caused severe pneumonia in patients with weaker immune system such as the elderlies and people with underlying diseases.",0.15000000000000002
"Although SARS-like viruses have been identified widely in bats in China, viruses identical to SARS-CoV have not yet been documented.",0.15000000000000002
"All human CoVs (HCoVs) is mainly of zoonotic origin, and most likely originate from bats [ 9 ].",0.15000000000000002
"1 ,  2  Shortly, a new coronavirus, temporally named 2019-nCov, was identified to be the cause of the disease, which is the seventh member of the family betacoronavirus.",0.15000000000000002
"Full-genome sequence analysis of 2019-nCoV revealed that belongs to betacoronavirus, but it is divergent from SARS-CoV and MERS-CoV that caused epidemics in the past [ 19 ].",0.15000000000000002
"Coronaviruses of other species including the murine coronavirus are genetically distant from this new coronavirus, indicating that 2019-nCoV did not originate from other animal hosts.",0.15000000000000002
"We acknowledge generation and provision of the genome sequence of 2019-nCoV (deposited in GenBank with the accession number  MN908947 )  by Professor Yong-Zhen Zhang from The Shanghai Public Health Clinical Center & School of Public Health, and scientists from the partner institutions including the Central Hospital of Wuhan, Huazhong University of Science and Technology, the Wuhan Center for Disease Control and Prevention, the National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control, and the University of Sydney, Sydney, Australia.",0.15000000000000002
"A study in 2015 has revealed that Middle East respiratory syndrome coronavirus (MERS-CoV) infection occurred in South Korea caused the rise of liver enzymes, implying liver function damage in patients infected with MERS-CoV [9].",0.15000000000000002
"The implementation of control measures in hospital settings, especially emergency rooms, will also be of prime importance, as has been shown by the examples of MERS-CoV in South Korea [ 15 ] and in Saudi Arabia [ 16 ].",0.15000000000000002
"Results  Our analysis suggests that the 2019-nCoV although closely related to BatCoV RaTG13 sequence throughout the genome (sequence similarity 96.3%), shows discordant clustering with the Bat-SARS-like coronavirus sequences.",0.15000000000000002
"There are currently 54 2019-nCoV complete genome sequences from the Global Initiative for Sharing all Influenza Data (Gisaid [7]) and from GenBank [8], plus two partial sequences obtained by the Spallanzani hospital in Rome, Italy (also from Gisaid).",0.15000000000000002
"We showed viral positive in 158 oral swabs, implying nCoV-2019 may be transmitted through airway.",0.15000000000000002
"It is made available under a CC-BY-NC 4.0 International license.perpetuity.Preliminary identification of potential vaccine targets for 2019-nCoV based on SARS-CoV immunological studies Syed Faraz Ahmed1#, Ahmed A. Quadeer1,#,*, and Matthew R. McKay1,2,* 1Department  of  Electronic  and  Computer  Engineering,  The  Hong  Kong  University  of  Science  and Technology, Hong Kong, China, 2Department  of  Chemical  and  Biological  Engineering,  The  Hong  Kong  University  of  Science  and Technology, Hong Kong, China *Correspondence should be addressed to eeaaquadeer@ust.hk and m.mckay@ust.hk.",0.15000000000000002
"Here we report the 27 identification and characterization of a novel coronavirus (nCoV-2019) which 28 caused an epidemic of acute respiratory syndrome in humans, in Wuhan, China.",0.15000000000000002
"Priorto intermediary cross-species infection, the coronaviruses SARS-CoV and MERS-CoV were also thoughtto have originated in bats [24,25,35,68,69].",0.15000000000000002
"Introduction Coronaviruses (CoVs) are members of the order Nidovirales, which includes enveloped viruses with large (~30kb), positive-sense single-stranded RNA genomes that yield a characteristic nested set of subgenomic mRNAs during replication in the cytoplasm of infected cells (1, 2).",0.15000000000000002
"Coronaviruses are a large family of viruses which usually circulate among animals which will cause fatal diseases, once they mutate and evolve to be able to infect human.",0.15000000000000002
"Materials and MethodsThe Wuhan seafood market pneumonia virus (2019-nCoV virus) isolate Wuhan-Hu-1 completereference genome of 29903 bp was downloaded from the NCBI database on January 23, 2020.",0.15000000000000002
"DiscussionPrior work elucidating the evolutionary history of the Wuhan 2019-nCoV virus had suggestedan origin from bats prior to zoonotic transmission [12,34,36,39,42,61].",0.15000000000000002
"Applied to the Wuhan 2019 Novel Coronavirus, our prediction demonstrated that several vertebrate-infectious coronaviruses have strong potential to infect human.",0.15000000000000002
Analysis of 2019-nCoV-S expression ( A ) and pseudotype incorporation ( B ) by Western blot.,0.15000000000000002
Extensive diversity of coronaviruses in batsfrom china.,0.15000000000000002
"Therefore, CR3022 has the potential to be developed as candidate therapeutics, alone or in combination with other neutralizing antibodies, for the prevention and treatment of 2019-nCoV infections.",0.15000000000000002
"However, examination of interaction between RBD of 2019-nCoV and human ACE2 depicted only one potential hydrophobic interaction between ACE2(L 79 , M 82 ) and RBD(F 486 ) and one cation-π interaction interaction ACE2(K 353 )/ RBD(Y 492 ).",0.15000000000000002
nCoV-2019 360 grown from Vero E6 cells was used for infection at multiplicity of infection 0.05.,0.15000000000000002
"Full-length 238 genome sequences of SARS-CoV BJ01, bat SARSr-CoV WIV1, bat coronavirus 239 RaTG13 and ZC45 were used as reference sequences.",0.15000000000000002
"A dataset have been built using 5 Highly similar sequences for Severe Acute Respiratory Syndrome Virus (SARS), 2 sequences for Middle East Respiratory Syndrome (MERS) and 5 Highly similar sequences for Bat Severe Acute Respiratory Syndrome Virus respectively.",0.15000000000000002
"Under the current health emergency, many researchers around the world engaged inthe investigation of the genetic and functional data of 2019-nCoV and compare to other coronaviruses to designproper infection control strategy2, 3 and seek potential drugs that can prevent and/or cure this serious epidemic.4–7On January 10, the genome sequence of 2019-nCoV was ﬁrst released on GenBank (accession MN908947)by Yong-Zhen Zhang’s group at Fudan University.8 Subsequently, phylogenetic analysis revealed that 2019-nCoV belonged to the Betacoronavirus genera and its closest whole-genome relatives are two SARS-like coro-naviruses from bats, i.e., ZC45 and ZXC21, which shared about 89% sequence identity with 2019-nCoV.6, 7Moreover, detailed sequence alignment data indicates that there is signiﬁcant genetics distance between the2019-nCoV and the human SARS-CoV.",0.15000000000000002
"Another distinctive coronavirus, known as MERS-CoV, was isolated from a man died of severe pneumonia and organ failure in Saudi Arabia at June 2012  ( 10 ) .",0.15000000000000002
The average incubation duration of 2019-nCoV infection was 4.8days.,0.15000000000000002
Overall our data indicates that the 2019-nCoV is not closely clustering  with  either  human  SARS-CoV  or  bat-SARS-CoV  like  strains  but  shares  a common ancestor.,0.15000000000000002
We first focused on 2019-nCoV cell tropism.,0.15000000000000002
"Our findings indicate that more rigorous control and prevention measures on early detection, diagnosis and treatment of cases infected with 2019-nCoV are needed to contain its further spread, including shortening the period from symptom onset to isolation of patients, effective contact tracing, quarantine and isolation of exposed persons, wearing respirator in the public, and reducing gathering activities and population mobility.",0.15000000000000002
These tests conﬁrm that the 2019-nCoV are from the genusBetacoronavirus.Sequences become very similar at lower taxonomic levels (sub-genera and species).,0.15000000000000002
"Based on our insight that the hepatitis C virus and the coronavirus use a similar viral genome replication mechanism, we reasoned that the FDA-approved drug EPCLUSA for the treatment of hepatitis C will also inhibit coronaviruses, including 2019-nCoV and those responsible for SARS and MERS.",0.15000000000000002
"Coronaviruses, members of the family  Coronaviridae  and subfamily  Coronavirinae , are enveloped positive-stranded RNA viruses which have spikes of glycoproteins projecting from their viral envelopes, thus exhibit a corona or halo-like appearance ( Masters and Perlman, 2013 ;  Cui et al., 2019 ) Coronaviruses are the causal pathogens for a wide spectrum of respiratory and gastrointestinal diseases in both wild and domestic animals, including birds, pigs, rodents, etc ( Dhama et al., 2014 ).",0.15000000000000002
"The Spearmantests corroborate that the 2019-nCoV virus is part of the Sarbecovirus sub-genus, as shown by CGR andML-DSP.",0.15000000000000002
The  2019-nCoV  outbreak has a fatality rate of 2% with significant impact on global health and economy.,0.15000000000000002
"2019-nCoV,  which  is  a  novel  coronavirus  emerged  in  Wuhan,  China,  at  the  end  of 2019, has caused at least infected 11,844 as of Feb 1, 2020.",0.15000000000000002
"IntroductionCoronaviruses are single-stranded positive-sense RNA viruses that are known to contain someof the largest viral genomes, up to around 32 kbp in length [1–5].",0.15000000000000002
"Based on our molecular insight that the hepatitis C virus and the coronavirus use a similar viral genome replication mechanism, we reasoned that the FDA-approved drug EPCLUSA (Sofosbuvir/Velpatasvir) for the treatment of hepatitis C will also inhibit the above coronaviruses, including 2019-nCoV.",0.15000000000000002
"On the basis of the SIR model, considering that 2019-nCoV is an infectious disease with a latent period, the E (Exposed) state and D (Death) state are added to construct the SEIRD propagation model.",0.15000000000000002
"Genetic diversity of mers-cov spike protein gene in saudi arabia.Journal of Infection and Public Health, 2019.",0.15000000000000002
"This clade includes two different clusters, the cluster IIa with Bat SARS-like coronavirus and the 2019-nCoV sequences whereas the cluster IIb with the Bat SARS-like coronavirus and the SARS virus sequences.",0.15000000000000002
"Moreover, in the phylogenetic tree, these two sequences are separated from the other Bat SARS-like coronavirus sequences, suggesting that this Bat SARS-like coronavirus is homologous and genetically more similar to the 2019-nCoV than to the other sequences of Bat SARS-like coronavirus.",0.15000000000000002
"Genome sequencing of samples from these patients confirmed that the culprit of these infections was a beta-coronavirus that has never been reported before, which was later named as 2019-nCoV [ 1 , 2 ].",0.15000000000000002
(e) Binding of monoclonal antibodies to 2019-nCoV RBD determined by ELISA.,0.15000000000000002
It is made available under a CC-BY 4.0 International license.perpetuity.6 of 22Test-1 classiﬁed the 2019-nCoV virus as belonging to the realm Riboviria.,0.15000000000000002
"Taken together with our receptor assay results, it may be possible that 2019-nCoV arose from recombination between clade 1 and the other clades.",0.15000000000000002
"The nCoV-2019 virus was then isolated from the bronchoalveolar lavage fluid of a critically ill patient, which can be neutralized by sera from several patients.",0.15000000000000002
"In addition, it is unknown yet whether 2019-nCoV can be transmitted through the digestive tract besides respiratory tract[ 5 ].",0.15000000000000002
"Provided by us, this technology could be used for fast delivery of a selective 2019-nCoV PLpro DUB substrate and probe, which could effectively be used as a screen/reporter assay to find drugs that can specifically inhibit the 2019-nCoV PLpro DUB by screening infected patient cells without the need to purify DUB from infected patient cells.",0.15000000000000002
"A newly identified coronavirus, 2019-nCoV, has been posing significant threats to public health since December 2019.",0.15000000000000002
"Nevertheless, all coronaviruses that exhibit close linkage with 2019-nCoV originated from bat, strongly suggesting that this new coronavirus originated from bat ( Fig 1a ).",0.15000000000000002
These consequences of infectivity pattern analysis illustrate that bat and mink may be two candidate reservoirs of 2019-nCov.These results warn us to beware of 2019-nCoV and guide us to further explore the properties and reservoir of it.,0.15000000000000002
Human coronavirus HKU1 spike protein uses O-acetylated sialic acid as an attachment receptor determinant and employs hemagglutinin-esterase protein as a receptor-destroying enzyme.,0.15000000000000002
"WHCV has 5’ and 3’ terminal sequences typical of the betacoronaviruses, with 265 nt at the 5’ terminal and 229 nt at the 3’ terminal region.",0.15000000000000002
"The basic reproductive number of this novel coronavirus has been estimated in recent studies (range from 2.6 to 6.47)[13, 20-24], suggesting its spread being as similar as or more efficient than seasonal influenza.",0.15000000000000002
"There is a consensus that these three bat viruses are most similar to 2019-nCoV,however, whether or not 2019-nCoV arose from a recombination event is still unknown [39–41].Regardless of the stance on recombination, current consensus holds that the hypothesis of2019-nCoV originating from bats is highly likely.",0.15000000000000002
"The clinical and virological features of the first imported case causing MERS-CoV outbreak in South Korea, 2015.",0.15000000000000002
"Still, the early 2019-nCoV genomes that have been sequenced and uploaded are over 99%similar, suggesting these infections result from a recent cross-species event [12,31,41].These prior analyses relied upon alignment-based methods to identify relationships between2019-nCoV and other coronaviruses with nucleotide and amino acid sequence similarities.",0.15000000000000002
"They have been categorized in  three  groups,  based  on  phylogenetic  analyses  and  antigenic  criteria  [2],  specifically:  1)  alpha-CoVs,  responsible for gastrointestinal disorders in human, dogs, pigs and cats; 2)  beta-CoVs, including the Bat coronavirus (BCoV), the human Severe Acute Respiratory Syndrome (SARS) virus and the Middle Eastern Respiratory Syndrome (MERS) virus; 3) gamma-CoVs, which infect avian species.",0.15000000000000002
These testsconﬁrm the ﬁndings in ML-DSP and are consistent with the 2019-nCoV virus as part of the sub-genusSarbecovirus.,0.15000000000000002
"Interestingly, besides the respiratory system,  substantial proportion of SARS and 2019-nCoV  patients  showed  signs  of  various  degrees  of  liver  damage,  the  mechanism  and implication of which have not yet been determined.",0.15000000000000002
The basic reproduction number ( R 0 ) was calculated from the RP model to assess the transmissibility of the 2019-nCoV.,0.15000000000000002
B-M27-VME was selective toward MERS PLpro (a much higher probe concentration was needed to inhibit UCH-L3).,0.15000000000000002
Coronavirus nonstructural protein 15 mediates evasion of dsRNA sensors and limits apoptosis in macrophages.,0.15000000000000002
"Lineage C coronaviruses include MERS-CoV as well as distantly related viruses such as HKU4, HKU5 and PDF-2180  28 ,  29 .",0.15000000000000002
"A novel coronavirus (2019-nCoV) associated with human to human transmission and severe human infection has been recently reported from the city of Wuhan in the Hubei province in China [ 17 ,  18 ].",0.15000000000000002
"Chaos Game Representation (CGR) plots at k = 7 of (a) 2019-nCoV / Wuhan seafood marketpneumonia virus isolate Wuhan-Hu-1/MN908947.3, (b) Betacoronavirus / CoV / Bat / Yunnan /RaTG13 /EPI_ISL_402131, (c) Betacoronavirus / Bat SARS-like coronavirus isolate bat-SL-CoVZC45/MG772933.1, (d) Betacoronavirus / Bat SARS-like coronavirus isolate bat-SL-CoVZXC21 /MG772934.1,(e) Alphacoronavirus /DQ811787 PRCV ISU-1, (f) Gammacoronavirus / Infectious bronchitis virus NGA/A116E7/2006/FN430415, and (g) Deltacoronavirus / PDCoV / USA / Illinois121 /2014/K J481931.Chaos plot vertices are assigned top left Cytosine, top right Guanine, bottom left Adenine and bottomright Thymine.Figure 4 shows the Chaos Game Representation (CGR) plots of different sequences from thefour different genera (Alphacoronavirus, Betacoronavirus, Deltacoronavirus, Gammacoronavirus) of thefamily Coronaviridae.",0.15000000000000002
"In contrast, the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) and the Middle East respiratory syndrome-associated coronavirus (MERS-CoV) are transmitted from animals to humans and cause severe respiratory diseases in afflicted human patients, SARS and MERS, respectively ( 2 ).",0.15000000000000002
"Most early cases of individualsinfected with 2019-nCoV had contact with the Huanan South China Seafood Market [26–31].Human-to-human transmission is conﬁrmed, further highlighting the need for continued intervention[34,61–63].",0.15000000000000002
"Furthermore, it was found that nCoV-2019 is 96% 34 identical at the whole genome level to a bat coronavirus.",0.15000000000000002
Detec-tion and molecular diversity of spike gene of porcine epidemic diarrhea virus in china.,0.15000000000000002
"After ruling out possible influenza and other coronaviruses by laboratory testing, the Chinese authorities isolated a new type of coronavirus (novel coronavirus, nCoV) on 7 th  January 2020, which was then named 2019-nCoV by WHO on 12 th  January [ 1 ].",0.15000000000000002
species,0.15000000000000002
genus,0.15000000000000002
subGenus,0.15000000000000002
family,0.15000000000000002
subFamily,0.15000000000000002
order,0.15000000000000002
subOrder,0.15000000000000002
subSpecies,0.15000000000000002
class,0.15000000000000002
phylum,0.15000000000000002
subPhylum,0.15000000000000002
host_is,0.15000000000000002
parent,0.15000000000000002
from_country,0.15000000000000002
from_division,0.15000000000000002
from_location,0.15000000000000002
from_mutate_branch,0.15000000000000002
produce,0.15000000000000002
effect,0.15000000000000002
interaction,0.15000000000000002
binding,0.15000000000000002
belong_to,0.15000000000000002
express,0.15000000000000002
translate,0.15000000000000002
therapeutic_method,0.15000000000000002
authors,0.15000000000000002
originating_lab,0.15000000000000002
submitting_lab,0.15000000000000002
gisaid_epi_isl,0.15000000000000002
collection_date,0.15000000000000002
nucleotide_mutation,0.15000000000000002
aa_mutation,0.15000000000000002
divergence,0.15000000000000002
virus_type,0.15000000000000002
drugbank_virus_id,0.15000000000000002
drugbank_drug_id,0.15000000000000002
atc_codes,0.15000000000000002
brand_names,0.15000000000000002
smiles_string_isomeric,0.15000000000000002
chemical_formula,0.15000000000000002
drug_type,0.15000000000000002
experimental_water_solubility,0.15000000000000002
molecular_weight_avg,0.15000000000000002
indication,0.15000000000000002
half_life,0.15000000000000002
pathways,0.15000000000000002
description,0.15000000000000002
pharmacology,0.15000000000000002
mechanism_of_action,0.15000000000000002
toxicity,0.15000000000000002
drug_category,0.15000000000000002
uniprotkb_entry_name,0.15000000000000002
similarity,0.15000000000000002
property_is,0.15000000000000002
virus_protein_interaction,0.15000000000000002
target,0.15000000000000002
cause,0.15000000000000002
subject_is,0.15000000000000002
object_is,0.15000000000000002
predicate_is,0.15000000000000002
reference_is,0.15000000000000002
title,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
null,0.15000000000000002
porcine epidemic diarrhea virus,0.15000000000000002
Murine coronavirus,0.15000000000000002
Coronaviruses,0.15000000000000002
HCoVs,0.15000000000000002
murine hepatitis virus,0.15000000000000002
bat SARS CoV W1V1,0.15000000000000002
bat-associated betacoronavirus,0.15000000000000002
SARS-CoV BJ01,0.15000000000000002
mouse hepatitis virus,0.15000000000000002
gamma-CoVs,0.15000000000000002
lentiviruses,0.15000000000000002
feline coronavirus,0.15000000000000002
HIV,0.15000000000000002